Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2017 | Apr. 27, 2017 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | CNA FINANCIAL CORP | |
Entity Central Index Key | 21,175 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Large Accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2017 | |
Document Fiscal Year Focus | 2,017 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 270,980,108 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Revenues | ||
Net earned premiums | $ 1,645 | $ 1,699 |
Net investment income | 545 | 435 |
Net realized investment gains (losses): | ||
Other-than-temporary impairment losses | (2) | (23) |
Other net realized investment gains (losses) | 38 | (13) |
Net realized investment gains (losses) on fixed maturity securities | 36 | (36) |
Other revenues | 104 | 97 |
Total revenues | 2,330 | 2,195 |
Claims, Benefits and Expenses | ||
Insurance claims and policyholders’ benefits | 1,293 | 1,408 |
Amortization of deferred acquisition costs | 305 | 307 |
Other operating expenses | 346 | 381 |
Interest | 43 | 42 |
Total claims, benefits and expenses | 1,987 | 2,138 |
Income before income tax | 343 | 57 |
Income tax (expense) benefit | (83) | 9 |
Net income | $ 260 | $ 66 |
Basic earnings per share (dollars per share) | $ 0.96 | $ 0.25 |
Diluted earnings per share (dollars per share) | 0.96 | 0.24 |
Dividends per share (dollars per share) | $ 2.25 | $ 2.25 |
Weighted Average Outstanding Common Stock and Common Stock Equivalents | ||
Basic (in shares) | 270.7 | 270.3 |
Diluted (in shares) | 271.7 | 270.9 |
Condensed Consolidated Stateme3
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 260 | $ 66 |
Other Comprehensive Income, Net of Tax | ||
Net unrealized gains on investments with other-than-temporary impairments | (4) | 5 |
Net unrealized gains on other investments | 67 | 234 |
Net unrealized gains on investments | 63 | 239 |
Foreign currency translation adjustment | 11 | 14 |
Pension and postretirement benefits | 7 | 6 |
Other comprehensive income, net of tax | 81 | 259 |
Total comprehensive income | $ 341 | $ 325 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Assets | ||
Fixed maturity securities at fair value (amortized cost of $38,269 and $38,361) | $ 40,980 | $ 40,905 |
Equity securities at fair value (cost of $112 and $106) | 120 | 110 |
Limited partnership investments | 2,389 | 2,371 |
Other invested assets | 40 | 36 |
Mortgage loans | 611 | 591 |
Short term investments | 1,139 | 1,407 |
Total investments | 45,279 | 45,420 |
Cash | 299 | 271 |
Reinsurance receivables (less allowance for uncollectible receivables of $38 and $37) | 4,395 | 4,416 |
Insurance receivables (less allowance for uncollectible receivables of $47 and $46) | 2,144 | 2,209 |
Accrued investment income | 431 | 405 |
Deferred acquisition costs | 626 | 600 |
Deferred income taxes | 267 | 379 |
Property and equipment at cost (less accumulated depreciation of $255 and $254) | 324 | 310 |
Goodwill | 146 | 145 |
Other assets | 1,290 | 1,078 |
Total assets | 55,201 | 55,233 |
Liabilities | ||
Claim and claim adjustment expenses | 22,260 | 22,343 |
Unearned premiums | 3,912 | 3,762 |
Future policy benefits | 10,491 | 10,326 |
Short term debt | 150 | 0 |
Long term debt | 2,560 | 2,710 |
Other liabilities (includes $41 and $50 due to Loews Corporation) | 4,135 | 4,123 |
Total liabilities | 43,508 | 43,264 |
Commitments and contingencies (Notes C and F) | ||
Stockholders' Equity | ||
Common stock ($2.50 par value; 500,000,000 shares authorized; 273,040,243 shares issued; 270,978,126 and 270,495,998 shares outstanding) | 683 | 683 |
Additional paid-in capital | 2,161 | 2,173 |
Retained earnings | 9,006 | 9,359 |
Accumulated other comprehensive income | (92) | (173) |
Treasury stock (2,062,117 and 2,544,245 shares), at cost | (65) | (73) |
Total stockholders’ equity | 11,693 | 11,969 |
Total liabilities and stockholders' equity | $ 55,201 | $ 55,233 |
Condensed Consolidated Balance5
Condensed Consolidated Balance Sheets - (Parenthetical) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Statement of Financial Position [Abstract] | ||
Amortized cost | $ 38,269 | $ 38,361 |
Cost | 112 | 106 |
Allowance for uncollectible reinsurance | 38 | 37 |
Allowance for uncollectible insurance receivables | 47 | 46 |
Accumulated depreciation | 255 | 254 |
Due to related parties | $ 41 | $ 50 |
Common stock, par value (dollars per share) | $ 2.50 | $ 2.50 |
Common stock, shares authorized (shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (shares) | 273,040,243 | 273,040,243 |
Common stock, shares outstanding (shares) | 270,978,126 | 270,495,998 |
Treasury stock, share (shares) | 2,062,117 | 2,544,245 |
Condensed Consolidated Stateme6
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Cash Flows from Operating Activities | ||
Net income | $ 260 | $ 66 |
Adjustments to reconcile net income to net cash flows provided by operating activities: | ||
Deferred income tax expense | 72 | 55 |
Trading portfolio activity | (6) | (3) |
Net realized investment (gains) losses | (36) | 36 |
Equity method investees | 38 | 262 |
Net amortization of investments | (12) | (4) |
Depreciation and amortization | 21 | 21 |
Changes in: | ||
Receivables, net | 89 | (317) |
Accrued investment income | (26) | (22) |
Deferred acquisition costs | (24) | (23) |
Insurance reserves | 135 | 511 |
Other assets | (37) | (89) |
Other liabilities | (206) | (168) |
Other, net | 14 | 9 |
Total adjustments | 22 | 268 |
Net cash flows provided by operating activities | 282 | 334 |
Dispositions: | ||
Fixed maturity securities - sales | 1,359 | 1,722 |
Fixed maturity securities - maturities, calls and redemptions | 823 | 490 |
Equity securities | 16 | 4 |
Limited partnerships | 57 | 89 |
Mortgage loans | 3 | 22 |
Purchases: | ||
Fixed maturity securities | (2,097) | (2,238) |
Equity securities | (7) | 0 |
Limited partnerships | (18) | (169) |
Mortgage loans | (23) | (19) |
Change in other investments | (1) | 0 |
Change in short term investments | 271 | 16 |
Purchases of property and equipment | (30) | (33) |
Disposals of property and equipment | 0 | 107 |
Other, net | 1 | 0 |
Net cash flows provided (used) by investing activities | 354 | (9) |
Cash Flows from Financing Activities | ||
Dividends paid to common stockholders | (609) | (609) |
Proceeds from the issuance of debt | 0 | 498 |
Repayment of debt | 0 | (358) |
Other, net | 0 | 0 |
Net cash flows used by financing activities | (609) | (469) |
Effect of foreign exchange rate changes on cash | 1 | (1) |
Net change in cash | 28 | (145) |
Cash, beginning of year | 271 | 387 |
Cash, end of period | $ 299 | $ 242 |
Condensed Consolidated Stateme7
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Millions | Total | Common Stock | Additional Paid-in Capital | Retained Earnings | AOCI Attributable to Parent | Treasury Stock |
Balance, beginning of year at Dec. 31, 2015 | $ 683 | $ 2,153 | $ 9,313 | $ (315) | $ (78) | |
Stock-based compensation | (7) | 5 | ||||
Dividends paid to common stockholders | (609) | |||||
Net income | $ 66 | 66 | ||||
Other comprehensive income | 259 | 259 | ||||
Balance, end of period at Mar. 31, 2016 | 11,470 | 683 | 2,146 | 8,770 | (56) | (73) |
Balance, beginning of year at Dec. 31, 2016 | 11,969 | 683 | 2,173 | 9,359 | (173) | (73) |
Stock-based compensation | (12) | 8 | ||||
Dividends paid to common stockholders | (613) | |||||
Net income | 260 | 260 | ||||
Other comprehensive income | 81 | 81 | ||||
Balance, end of period at Mar. 31, 2017 | $ 11,693 | $ 683 | $ 2,161 | $ 9,006 | $ (92) | $ (65) |
General
General | 3 Months Ended |
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
General | General Basis of Presentation The Condensed Consolidated Financial Statements include the accounts of CNA Financial Corporation (CNAF) and its subsidiaries. Collectively, CNAF and its subsidiaries are referred to as CNA or the Company. Loews Corporation (Loews) owned approximately 90% of the outstanding common stock of CNAF as of March 31, 2017 . The accompanying Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). Intercompany amounts have been eliminated. Certain financial information that is normally included in annual financial statements prepared in accordance with GAAP, including certain financial statement notes, is not required for interim reporting purposes and has been condensed or omitted. These statements should be read in conjunction with the Consolidated Financial Statements and notes thereto included in CNAF's Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended December 31, 2016 , including the summary of significant accounting policies in Note A. The preparation of Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. The interim financial data as of March 31, 2017 and for the three months ended March 31, 2017 and 2016 is unaudited. However, in the opinion of management, the interim data includes all adjustments, including normal recurring adjustments, necessary for a fair statement of the Company's results for the interim periods. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Recently Adopted Accounting Standards Updates (ASU) In March 2016, the Financial Accounting Standards Board (FASB) issued ASU No. 2016-09, Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The updated accounting guidance simplifies the accounting for share-based payment award transactions, including income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. As of January 1, 2017, the Company adopted the updated accounting guidance and began recognizing excess tax benefits or deficiencies on vesting or settlement of awards as an income tax benefit or expense within net income, instead of additional paid-in capital as required under previous guidance. The related cash flows are now classified within operating activities. As a result of this change, excess tax benefits are no longer included in assumed proceeds under the treasury stock method of calculating earnings per share. The impact of the accounting change resulted in a decrease of $3 million to income tax expense for the three months ended March 31, 2017. Accounting Standards Pending Adoption In May 2014, the FASB issued ASU No. 2014-09, Revenue Recognition (Topic 606): Revenue from Contracts with Customers . The standard excludes from its scope the accounting for insurance contracts, financial instruments, and certain other agreements that are governed under other GAAP guidance. The updated guidance requires an entity to recognize revenue as performance obligations are met, in an amount that reflects the consideration the entity is entitled to receive for the transfer of the promised goods or services. The standard is effective for interim and annual reporting periods beginning after December 15, 2017 and may be applied retrospectively or through a cumulative effect adjustment to retained earnings at the date of adoption. As insurance contracts are out of scope, the Company anticipates the primary change will be to revenue recognition for certain of our warranty products and services. The Company has not made a decision on the method of adoption and is currently evaluating the effect the updated guidance will have on the Company’s financial statements, but we do not currently believe ASU 2014-09 will have a material effect on the Company's results of operations or financial position. In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The updated accounting guidance requires changes to the reporting model for financial instruments. The guidance is effective for interim and annual periods beginning after December 15, 2017. The Company is currently evaluating the effect the guidance will have on the Company's financial statements, and expects the primary change for the Company to be the requirement for equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842): Accounting for Leases. The updated accounting guidance requires lessees to recognize on the balance sheet the assets and liabilities for the rights and obligations created by all leases, including those historically accounted for as operating leases. The guidance is effective for interim and annual periods beginning after December 15, 2018. The Company is currently evaluating the effect the updated guidance will have on the Company's financial statements. It is expected that assets and liabilities will increase based on the present value of remaining lease payments for leases in place at the adoption date; however, this is not expected to be material to the Company's results of operations or financial position. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The updated accounting guidance requires changes to the recognition of credit losses on financial instruments not accounted for at fair value through net income. The guidance is effective for interim and annual periods beginning after December 15, 2019. The Company is currently evaluating the effect the guidance will have on the Company's financial statements, but expects the primary changes to be the use of the expected credit loss model for its mortgage loan portfolio and reinsurance receivables and the presentation of credit losses within the available-for-sale fixed maturities portfolio through an allowance method rather than as a direct write-down. The expected credit loss model will require a financial asset to be presented at the net amount expected to be collected. The allowance method for available-for-sale debt securities will allow the Company to record reversals of credit losses if the estimate of credit losses declines. In March 2017, the FASB issued ASU No. 2017-07, Compensation-Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost . The updated accounting guidance requires changes to the presentation of the components of net periodic benefit cost on the income statement by requiring service cost to be presented with other employee compensation costs and other components of net periodic pension cost to be presented outside of any subtotal of operating income. The ASU also stipulates that only the service cost component of net benefit cost is eligible for capitalization. The guidance is effective for interim and annual periods beginning after December 15, 2017. The Company is currently evaluating the effect the guidance will have on the Company's financial statements. |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Mar. 31, 2015 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share Earnings per share is based on the weighted average number of outstanding common shares. Basic earnings (loss) per share excludes the effect of dilutive securities and is computed by dividing Net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the three months ended March 31, 2017 and 2016 , approximately 974 thousand and 542 thousand potential shares attributable to exercises or conversions into common stock under stock-based employee compensation plans were included in the calculation of diluted earnings per share. For those same periods, approximately 148 thousand and 180 thousand potential shares attributable to exercises or conversions into common stock under stock-based employee compensation plans were not included in the calculation of diluted earnings per share, because the effect would have been antidilutive. |
Investments
Investments | 3 Months Ended |
Mar. 31, 2017 | |
Investments [Abstract] | |
Investments | Investments The significant components of Net investment income are presented in the following table. Three months ended March 31 (In millions) 2017 2016 Fixed maturity securities $ 455 $ 446 Equity securities 1 3 Limited partnership investments 90 (14 ) Mortgage loans 7 9 Short term investments 3 3 Trading portfolio 2 2 Other 1 — Gross investment income 559 449 Investment expense (14 ) (14 ) Net investment income $ 545 $ 435 Net realized investment gains (losses) are presented in the following table. Three months ended March 31 (In millions) 2017 2016 Net realized investment gains (losses): Fixed maturity securities: Gross realized gains $ 49 $ 45 Gross realized losses (17 ) (62 ) Net realized investment gains (losses) on fixed maturity securities 32 (17 ) Equity securities: Gross realized gains — — Gross realized losses — (5 ) Net realized investment gains (losses) on equity securities — (5 ) Derivatives 1 (7 ) Short term investments and other 3 (7 ) Net realized investment gains (losses) $ 36 $ (36 ) Net realized investment losses for the three months ended March 31, 2016 include $8 million related to the first quarter 2016 redemption of the Company's $350 million senior notes due August 2016. The components of Other-than-temporary impairment (OTTI) losses recognized in earnings by asset type are presented in the following table. Three months ended March 31 (In millions) 2017 2016 Fixed maturity securities available-for-sale: Corporate and other bonds $ 2 $ 16 Asset-backed: Residential mortgage-backed — — Other asset-backed — 2 Total asset-backed — 2 Total fixed maturity securities available-for-sale 2 18 Equity securities available-for-sale -- Common stock — 5 OTTI losses recognized in earnings $ 2 $ 23 The following tables present a summary of fixed maturity and equity securities. March 31, 2017 Cost or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Unrealized OTTI Losses (Gains) (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 17,838 $ 1,428 $ 37 $ 19,229 $ (1 ) States, municipalities and political subdivisions 12,261 1,219 31 13,449 (12 ) Asset-backed: Residential mortgage-backed 4,672 121 50 4,743 (27 ) Commercial mortgage-backed 1,902 52 19 1,935 — Other asset-backed 1,043 10 4 1,049 — Total asset-backed 7,617 183 73 7,727 (27 ) U.S. Treasury and obligations of government-sponsored enterprises 95 8 — 103 — Foreign government 419 14 1 432 — Redeemable preferred stock 19 1 — 20 — Total fixed maturity securities available-for-sale 38,249 2,853 142 40,960 $ (40 ) Total fixed maturity securities trading 20 20 Equity securities available-for-sale: Common stock 20 5 — 25 Preferred stock 92 5 2 95 Total equity securities available-for-sale 112 10 2 120 Total $ 38,381 $ 2,863 $ 144 $ 41,100 December 31, 2016 Cost or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Unrealized OTTI Losses (Gains) (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 17,711 $ 1,323 $ 76 $ 18,958 $ (1 ) States, municipalities and political subdivisions 12,060 1,213 33 13,240 (16 ) Asset-backed: Residential mortgage-backed 5,004 120 51 5,073 (28 ) Commercial mortgage-backed 2,016 48 24 2,040 — Other asset-backed 1,022 8 5 1,025 — Total asset-backed 8,042 176 80 8,138 (28 ) U.S. Treasury and obligations of government-sponsored enterprises 83 10 — 93 — Foreign government 435 13 3 445 — Redeemable preferred stock 18 1 — 19 — Total fixed maturity securities available-for-sale 38,349 2,736 192 40,893 $ (45 ) Total fixed maturity securities trading 12 12 Equity securities available-for-sale: Common stock 13 6 — 19 Preferred stock 93 2 4 91 Total equity securities available-for-sale 106 8 4 110 Total $ 38,467 $ 2,744 $ 196 $ 41,015 The net unrealized gains on investments included in the tables above are recorded as a component of Accumulated other comprehensive income (AOCI). When presented in AOCI, these amounts are net of tax and any required Shadow Adjustments. To the extent that unrealized gains on fixed income securities supporting certain products within the Life & Group Non-Core segment would result in a premium deficiency if realized, a related increase in Insurance reserves is recorded, net of tax, as a reduction of net unrealized gains through Other comprehensive income (loss) (Shadow Adjustments). As of March 31, 2017 and December 31, 2016 , the net unrealized gains on investments included in AOCI were correspondingly reduced by Shadow Adjustments of $1,060 million and $1,014 million . The following tables present the estimated fair value and gross unrealized losses of fixed maturity and equity securities in a gross unrealized loss position by the length of time in which the securities have continuously been in that position. Less than 12 Months 12 Months or Longer Total March 31, 2017 Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 1,915 $ 29 $ 134 $ 8 $ 2,049 $ 37 States, municipalities and political subdivisions 845 31 33 — 878 31 Asset-backed: Residential mortgage-backed 2,188 44 170 6 2,358 50 Commercial mortgage-backed 590 15 139 4 729 19 Other asset-backed 256 4 28 — 284 4 Total asset-backed 3,034 63 337 10 3,371 73 U.S. Treasury and obligations of government-sponsored enterprises 31 — — — 31 — Foreign government 89 1 — — 89 1 Total fixed maturity securities available-for-sale 5,914 124 504 18 6,418 142 Equity securities available-for-sale: Common stock 2 — — — 2 — Preferred stock 15 2 — — 15 2 Total equity securities available-for-sale 17 2 — — 17 2 Total $ 5,931 $ 126 $ 504 $ 18 $ 6,435 $ 144 Less than 12 Months 12 Months or Longer Total December 31, 2016 Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 2,615 $ 61 $ 254 $ 15 $ 2,869 $ 76 States, municipalities and political subdivisions 959 32 23 1 982 33 Asset-backed: Residential mortgage-backed 2,136 44 201 7 2,337 51 Commercial mortgage-backed 756 22 69 2 825 24 Other asset-backed 398 5 24 — 422 5 Total asset-backed 3,290 71 294 9 3,584 80 U.S. Treasury and obligations of government-sponsored enterprises 5 — — — 5 — Foreign government 108 3 — — 108 3 Total fixed maturity securities available-for-sale 6,977 167 571 25 7,548 192 Equity securities available-for-sale -- Preferred stock 12 — 13 4 25 4 Total $ 6,989 $ 167 $ 584 $ 29 $ 7,573 $ 196 Based on current facts and circumstances, the Company believes the unrealized losses presented in the March 31, 2017 securities in a gross unrealized loss position table above are not indicative of the ultimate collectibility of the current amortized cost of the securities, but rather are attributable to changes in interest rates, credit spreads and other factors. The Company has no current intent to sell securities with unrealized losses, nor is it more likely than not that it will be required to sell prior to recovery of amortized cost; accordingly, the Company has determined that there are no additional OTTI losses to be recorded as of March 31, 2017 . The following table presents the activity related to the pretax credit loss component reflected in Retained earnings on fixed maturity securities still held as of March 31, 2017 and 2016 for which a portion of an OTTI loss was recognized in Other comprehensive income (loss). Three months ended March 31 (In millions) 2017 2016 Beginning balance of credit losses on fixed maturity securities $ 36 $ 53 Reductions for securities sold during the period (4 ) (5 ) Ending balance of credit losses on fixed maturity securities $ 32 $ 48 Contractual Maturity The following table presents available-for-sale fixed maturity securities by contractual maturity. March 31, 2017 December 31, 2016 (In millions) Cost or Amortized Cost Estimated Fair Value Cost or Amortized Cost Estimated Fair Value Due in one year or less $ 1,655 $ 1,701 $ 1,779 $ 1,828 Due after one year through five years 7,539 7,918 7,566 7,955 Due after five years through ten years 15,645 16,176 15,892 16,332 Due after ten years 13,410 15,165 13,112 14,778 Total $ 38,249 $ 40,960 $ 38,349 $ 40,893 Actual maturities may differ from contractual maturities because certain securities may be called or prepaid. Securities not due at a single date are allocated based on weighted average life. Derivative Financial Instruments The Company holds an embedded derivative on a funds withheld liability with a notional value of $172 million and $174 million as of March 31, 2017 and December 31, 2016 and a fair value of $2 million and $3 million as of March 31, 2017 and December 31, 2016 . The embedded derivative on funds withheld liability is accounted for separately and reported with the funds withheld liability in Other liabilities on the Condensed Consolidated Balance Sheets. Investment Commitments As of March 31, 2017 , the Company had committed approximately $394 million to future capital calls from various third-party limited partnership investments in exchange for an ownership interest in the related partnerships. As of March 31, 2017 , the Company had mortgage loan commitments of $46 million representing signed loan applications received and accepted. The Company invests in various privately placed debt securities, including bank loans, as part of its overall investment strategy and has committed to additional future purchases, sales and funding. Purchases and sales of privately placed debt securities are recorded once funded. As of March 31, 2017 , the Company had commitments to purchase or fund additional amounts of $217 million and sell $196 million under the terms of such securities. |
Fair Value
Fair Value | 3 Months Ended |
Mar. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair Value | Fair Value Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable. Level 1 - Quoted prices for identical instruments in active markets. Level 2 - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level 3 - Valuations derived from valuation techniques in which one or more significant inputs are not observable. Prices may fall within Level 1, 2 or 3 depending upon the methodology and inputs used to estimate fair value for each specific security. In general, the Company seeks to price securities using third-party pricing services. Securities not priced by pricing services are submitted to independent brokers for valuation and, if those are not available, internally developed pricing models are used to value assets using a methodology and inputs the Company believes market participants would use to value the assets. Prices obtained from third-party pricing services or brokers are not adjusted by the Company. The Company performs control procedures over information obtained from pricing services and brokers to ensure prices received represent a reasonable estimate of fair value and to confirm representations regarding whether inputs are observable or unobservable. Procedures may include i) the review of pricing service methodologies or broker pricing qualifications, ii) back-testing, where past fair value estimates are compared to actual transactions executed in the market on similar dates, iii) exception reporting, where period-over-period changes in price are reviewed and challenged with the pricing service or broker based on exception criteria, iv) deep dives, where the Company performs an independent analysis of the inputs and assumptions used to price individual securities and v) pricing validation, where prices received are compared to prices independently estimated by the Company. Assets and Liabilities Measured at Fair Value Assets and liabilities measured at fair value on a recurring basis are presented in the following tables. March 31, 2017 Total Assets/Liabilities at Fair Value (In millions) Level 1 Level 2 Level 3 Assets Fixed maturity securities: Corporate and other bonds $ — $ 19,125 $ 121 $ 19,246 States, municipalities and political subdivisions — 13,451 1 13,452 Asset-backed: Residential mortgage-backed — 4,617 126 4,743 Commercial mortgage-backed — 1,922 13 1,935 Other asset-backed — 932 117 1,049 Total asset-backed — 7,471 256 7,727 U.S. Treasury and obligations of government-sponsored enterprises 103 — — 103 Foreign government — 432 — 432 Redeemable preferred stock 20 — — 20 Total fixed maturity securities 123 40,479 378 40,980 Equity securities 101 — 19 120 Other invested assets — 5 — 5 Short term investments 225 829 — 1,054 Life settlement contracts, included in Other assets — — 46 46 Total assets $ 449 $ 41,313 $ 443 $ 42,205 Liabilities Other liabilities $ — $ (2 ) $ — $ (2 ) Total liabilities $ — $ (2 ) $ — $ (2 ) December 31, 2016 Total Assets/Liabilities at Fair Value (In millions) Level 1 Level 2 Level 3 Assets Fixed maturity securities: Corporate and other bonds $ — $ 18,840 $ 130 $ 18,970 States, municipalities and political subdivisions — 13,239 1 13,240 Asset-backed: Residential mortgage-backed — 4,944 129 5,073 Commercial mortgage-backed — 2,027 13 2,040 Other asset-backed — 968 57 1,025 Total asset-backed — 7,939 199 8,138 U.S. Treasury and obligations of government-sponsored enterprises 93 — — 93 Foreign government — 445 — 445 Redeemable preferred stock 19 — — 19 Total fixed maturity securities 112 40,463 330 40,905 Equity securities 91 — 19 110 Other invested assets — 5 — 5 Short term investments 475 853 — 1,328 Life settlement contracts, included in Other assets — — 58 58 Total assets $ 678 $ 41,321 $ 407 $ 42,406 Liabilities Other liabilities $ — $ (3 ) $ — $ (3 ) Total liabilities $ — $ (3 ) $ — $ (3 ) The tables below present a reconciliation for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3). Level 3 (In millions) Balance as of January 1, 2017 Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)* Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) Purchases Sales Settlements Transfers into Level 3 Transfers out of Level 3 Balance as of March 31, 2017 Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss)* Fixed maturity securities: Corporate and other bonds $ 130 $ — $ 1 $ 5 $ (1 ) $ (14 ) $ — $ — $ 121 $ — States, municipalities and political subdivisions 1 — — — — — — — 1 — Asset-backed: Residential mortgage-backed 129 1 2 — — (6 ) — — 126 — Commercial mortgage-backed 13 — — — — — — — 13 — Other asset-backed 57 (1 ) — 38 — — 28 (5 ) 117 — Total asset-backed 199 — 2 38 — (6 ) 28 (5 ) 256 — Total fixed maturity securities 330 — 3 43 (1 ) (20 ) 28 (5 ) 378 — Equity securities 19 — 1 1 (2 ) — — — 19 — Derivative financial instruments — 1 — — (1 ) — — — — — Life settlement contracts 58 6 — — (13 ) (5 ) — — 46 — Total $ 407 $ 7 $ 4 $ 44 $ (17 ) $ (25 ) $ 28 $ (5 ) $ 443 $ — Level 3 (In millions) Balance as of January 1, 2016 Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)* Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) Purchases Sales Settlements Transfers into Level 3 Transfers out of Level 3 Balance as of March 31, 2016 Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2016 recognized in Net income (loss)* Fixed maturity securities: Corporate and other bonds $ 168 $ (1 ) $ 4 $ 53 $ (16 ) $ (3 ) $ — $ (12 ) $ 193 $ — States, municipalities and political subdivisions 2 — — — — — — — 2 — Asset-backed: Residential mortgage-backed 134 1 — — — (5 ) — (2 ) 128 — Commercial mortgage-backed 22 — — 9 — — — (4 ) 27 — Other asset-backed 53 — — — — — 2 (5 ) 50 — Total asset-backed 209 1 — 9 — (5 ) 2 (11 ) 205 — Total fixed maturity securities 379 — 4 62 (16 ) (8 ) 2 (23 ) 400 — Equity securities 20 — (1 ) — — — — — 19 — Life settlement contracts 74 4 — — — (6 ) — — 72 1 Total $ 473 $ 4 $ 3 $ 62 $ (16 ) $ (14 ) $ 2 $ (23 ) $ 491 $ 1 *Net realized and unrealized gains and losses from Level 3 securities and derivatives are reported in Net income (loss) as follows: Major Category of Assets and Liabilities Condensed Consolidated Statements of Operations Line Items Fixed maturity securities available-for-sale (1) Net realized investment gains (losses) Fixed maturity securities trading Net investment income Equity securities (1) Net realized investment gains (losses) Other invested assets - Derivative financial instruments held in a trading portfolio Net investment income Other invested assets - Derivative financial instruments not held in a trading portfolio Net realized investment gains (losses) Life settlement contracts Other revenues Other liabilities - Derivative financial instruments Net realized investment gains (losses) (1) Unrealized gains and losses are reported within AOCI. Securities may be transferred in or out of levels within the fair value hierarchy based on the availability of observable market information and quoted prices used to determine the fair value of the security. The availability of observable market information and quoted prices varies based on market conditions and trading volume. During the three months ended March 31, 2017 and 2016 there were no transfers between Level 1 and Level 2. The Company's policy is to recognize transfers between levels at the beginning of quarterly reporting periods. Valuation Methodologies and Inputs The following section describes the valuation methodologies and relevant inputs used to measure different financial instruments at fair value, including an indication of the level in the fair value hierarchy in which the instruments are generally classified. Fixed Maturity Securities Level 1 securities include highly liquid and exchange traded bonds and redeemable preferred stock, valued using quoted market prices. Level 2 securities include most other fixed maturity securities as the significant inputs are observable in the marketplace. All classes of Level 2 fixed maturity securities are valued using a methodology based on information generated by market transactions involving identical or comparable assets, a discounted cash flow methodology, or a combination of both when necessary. Common inputs for all classes of fixed maturity securities include prices from recently executed transactions of similar securities, marketplace quotes, benchmark yields, spreads off benchmark yields, interest rates and U.S. Treasury or swap curves. Specifically for asset-backed securities, key inputs include prepayment and default projections based on past performance of the underlying collateral and current market data. Fixed maturity securities are primarily assigned to Level 3 in cases where broker/dealer quotes are significant inputs to the valuation, and there is a lack of transparency as to whether these quotes are based on information that is observable in the marketplace. Level 3 securities also include private placement debt securities whose fair value is determined using internal models with inputs that are not market observable. Equity Securities Level 1 equity securities include publicly traded securities valued using quoted market prices. Level 2 securities are primarily non-redeemable preferred stocks and common stocks valued using pricing for similar securities, recently executed transactions and other pricing models utilizing market observable inputs. Level 3 securities are primarily priced using broker/dealer quotes and internal models with inputs that are not market observable. Other Invested Assets The fair value of Federal Home Loan Bank of Chicago (FHLBC) stock is equal to par because it can only be redeemed by the FHLBC at par or sold to another member of the FHLBC at par and is classified as Level 2. As of March 31, 2017 and December 31, 2016 , there were approximately $35 million and $31 million respectively of overseas deposits within other invested assets, which can be redeemed at net asset value in 90 days or less. Overseas deposits are excluded from the fair value hierarchy, because their fair value is recorded using the net asset value per share (or equivalent) practical expedient. Short Term Investments Securities that are actively traded or have quoted prices are classified as Level 1. These securities include money market funds and treasury bills. Level 2 primarily includes commercial paper, for which all inputs are market observable. Fixed maturity securities purchased within one year of maturity are classified consistent with fixed maturity securities discussed above. Short term investments as presented in the tables above differ from the amounts presented on the Condensed Consolidated Balance Sheets because certain short term investments, such as time deposits, are not measured at fair value. Life Settlement Contracts The Company accounts for its investment in life settlement contracts using the fair value method. Historically, the fair value of life settlement contracts was determined as the present value of the anticipated death benefits less anticipated premium payments based on contract terms that are distinct for each insured, as well as the Company's own assumptions for mortality, premium expense and the rate of return that a buyer would require on the contracts. The entire portfolio of life settlement contracts, which is included within the Life and Group Non-Core segment, was determined to be held for sale as of December 31, 2016 as the Company reached an agreement on terms to sell the portfolio. As such, the Company adjusted the fair value to the estimated sales proceeds less cost to sell. The definitive Purchase and Sale Agreement (PSA) related to the portfolio was executed on March 7, 2017 (sale date). In connection therewith, the life settlement contracts and related sale proceeds were placed in escrow until the buyer is recognized as the owner and beneficiary of each individual life settlement contract by the life insurance company that issued the policy. A number of contracts have been released from escrow as of March 31, 2017. The Company derecognized these contracts and recorded the consideration, including a note receivable, which is payable over three years and is carried at amortized cost less any valuation allowance. The note receivable is included within Other assets on the Condensed Consolidated Balance Sheets and interest income is accreted to the principal balance of the note receivable. The remaining contracts still in escrow have not been derecognized and were measured at the fair value per the PSA. The fair value of the Company's investments in life settlement contracts were $46 million and $58 million as of March 31, 2017 and December 31, 2016 , and are included in Other assets on the Condensed Consolidated Balance Sheets. Despite the sale, the contracts have been classified as Level 3 as there is not an active market for life settlement contracts. The cash receipts and payments related to the life settlement contracts prior to the sale date are included in Cash Flows from operating activities on the Condensed Consolidated Statements of Cash Flows. Cash receipts related to the sale of the life settlement contracts, as well as principal payments on the note receivable, are included in Cash Flows from investing activities. Derivative Financial Investments Level 2 securities primarily include the embedded derivative on the funds withheld liability. The embedded derivative on funds withheld liability is valued using the change in fair value of the assets supporting the funds withheld liability, which are fixed maturity securities valued with observable inputs. Significant Unobservable Inputs The following tables present quantitative information about the significant unobservable inputs utilized by the Company in the fair value measurements of Level 3 assets. Valuations for assets and liabilities not presented in the tables below are primarily based on broker/dealer quotes for which there is a lack of transparency as to inputs used to develop the valuations. The quantitative detail of these unobservable inputs is neither provided nor reasonably available to the Company. The valuation of life settlement contracts was based on the terms of the sale of the contracts to a third party, therefore, the contracts are not included in the table below. March 31, 2017 Estimated Fair Value (In millions) Valuation Technique(s) Unobservable Input(s) Range (Weighted Average) Fixed maturity securities $ 122 Discounted cash flow Credit spread 2% - 40% (4%) December 31, 2016 Estimated Fair Value Valuation Technique(s) Unobservable Input(s) Range (Weighted Average) Fixed maturity securities $ 106 Discounted cash flow Credit spread 2% - 40% (4%) For fixed maturity securities, an increase to the credit spread assumptions would result in a lower fair value measurement. Financial Assets and Liabilities Not Measured at Fair Value The carrying amount and estimated fair value of the Company's financial assets and liabilities which are not measured at fair value on the Condensed Consolidated Balance Sheets are presented in the following tables. March 31, 2017 Carrying Amount Estimated Fair Value (In millions) Level 1 Level 2 Level 3 Total Assets Mortgage loans $ 611 $ — $ — $ 616 $ 616 Note receivable 10 — — 10 10 Liabilities Short term debt $ 150 $ — $ 156 $ — $ 156 Long term debt 2,560 — 2,811 — 2,811 December 31, 2016 Carrying Estimated Fair Value (In millions) Level 1 Level 2 Level 3 Total Assets Mortgage loans $ 591 $ — $ — $ 594 $ 594 Liabilities Long term debt $ 2,710 $ — $ 2,952 $ — $ 2,952 The following methods and assumptions were used to estimate the fair value of these financial assets and liabilities. The fair values of mortgage loans were based on the present value of the expected future cash flows discounted at the current interest rate for origination of similar quality loans, adjusted for specific loan risk. The fair value of the note receivable was based on the present value of the expected future cash flows discounted at the current interest rate for origination of similar notes, adjusted for specific credit risk. The Company's senior notes and debentures were valued based on observable market prices. The fair value for other debt was estimated using discounted cash flows based on current incremental borrowing rates for similar borrowing arrangements. The carrying amounts reported on the Condensed Consolidated Balance Sheets for Cash, Short term investments not carried at fair value, Accrued investment income and certain Other assets and Other liabilities approximate fair value due to the short term nature of these items. These assets and liabilities are not listed in the tables above. |
Claim and Claim Adjustment Expe
Claim and Claim Adjustment Expense Reserves | 3 Months Ended |
Mar. 31, 2017 | |
Liability for Claims and Claims Adjustment Expense [Abstract] | |
Claim and Claim Adjustment Expense Reserves | Claim and Claim Adjustment Expense Reserves The Company's property and casualty insurance claim and claim adjustment expense reserves represent the estimated amounts necessary to resolve all outstanding claims, including incurred but not reported (IBNR) claims as of the reporting date. The Company's reserve projections are based primarily on detailed analysis of the facts in each case, the Company's experience with similar cases and various historical development patterns. Consideration is given to such historical patterns as claim reserving trends and settlement practices, loss payments, pending levels of unpaid claims and product mix, as well as court decisions, economic conditions, including inflation, and public attitudes. All of these factors can affect the estimation of claim and claim adjustment expense reserves. Establishing claim and claim adjustment expense reserves, including claim and claim adjustment expense reserves for catastrophic events that have occurred, is an estimation process. Many factors can ultimately affect the final settlement of a claim and, therefore, the necessary reserve. Changes in the law, results of litigation, medical costs, the cost of repair materials and labor rates can all affect ultimate claim costs. In addition, time can be a critical part of reserving determinations since the longer the span between the incidence of a loss and the payment or settlement of the claim, the more variable the ultimate settlement amount can be. Accordingly, short-tail claims, such as property damage claims, tend to be more reasonably estimable than long-tail claims, such as workers' compensation, general liability and professional liability claims. Adjustments to prior year reserve estimates, if necessary, are reflected in the results of operations in the period that the need for such adjustments is determined. There can be no assurance that the Company's ultimate cost for insurance losses will not exceed current estimates. Catastrophes are an inherent risk of the property and casualty insurance business and have contributed to material period-to-period fluctuations in the Company's results of operations and/or equity. The Company reported catastrophe losses, net of reinsurance, of $34 million and $36 million for three months ended March 31, 2017 and 2016 . Catastrophe losses in the first quarter of 2017 related primarily to U.S. weather-related events. Liability for Unpaid Claim and Claim Adjustment Expenses Rollforward The following table presents a reconciliation between beginning and ending claim and claim adjustment expense reserves, including claim and claim adjustment expense reserves of the Life & Group Non-Core segment. For the three months ended March 31 (In millions) 2017 2016 Reserves, beginning of year: Gross $ 22,343 $ 22,663 Ceded 4,094 4,087 Net reserves, beginning of year 18,249 18,576 Net incurred claim and claim adjustment expenses: Provision for insured events of current year 1,207 1,224 Decrease in provision for insured events of prior years (82 ) (45 ) Amortization of discount 48 48 Total net incurred (1) 1,173 1,227 Net payments attributable to: Current year events (68 ) (76 ) Prior year events (1,184 ) (1,147 ) Total net payments (1,252 ) (1,223 ) Foreign currency translation adjustment and other 14 39 Net reserves, end of period 18,184 18,619 Ceded reserves, end of period 4,076 4,399 Gross reserves, end of period $ 22,260 $ 23,018 (1) Total net incurred above does not agree to Insurance claims and policyholders' benefits as reflected on the Condensed Consolidated Statements of Operations due to amounts related to retroactive reinsurance deferred gain accounting, uncollectible reinsurance and loss deductible receivables, and benefit expenses related to future policy benefits, which are not reflected in the table above. Net Prior Year Development Changes in estimates of claim and allocated claim adjustment expense reserves and premium accruals, net of reinsurance, for prior years are defined as net prior year development. These changes can be favorable or unfavorable. The following tables and discussion present the net prior year development recorded for Specialty, Commercial, International and Corporate & Other Non-Core segments. Three months ended March 31, 2017 (In millions) Specialty Commercial International Corporate & Other Non-Core Total Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development $ (31 ) $ (24 ) $ (2 ) $ — $ (57 ) Pretax (favorable) unfavorable premium development (5 ) 37 (7 ) — 25 Total pretax (favorable) unfavorable net prior year development $ (36 ) $ 13 $ (9 ) $ — $ (32 ) Three months ended March 31, 2016 (In millions) Specialty Commercial International Corporate & Other Non-Core Total Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development $ (34 ) $ (14 ) $ (4 ) $ — $ (52 ) Pretax (favorable) unfavorable premium development (11 ) (2 ) (1 ) — (14 ) Total pretax (favorable) unfavorable net prior year development $ (45 ) $ (16 ) $ (5 ) $ — $ (66 ) Premium development can occur in the property and casualty business when there is a change in exposure on auditable policies or when premium accruals differ from processed premium. Audits on policies usually occur in a period after the expiration date of the policy. See further information on the premium development in the Commercial segment for the three months ended March 31, 2017 within Note F. Specialty The following table presents further detail of the net prior year claim and allocated claim adjustment expense reserve development (development) recorded for the Specialty segment. Three months ended March 31 (In millions) 2017 2016 Pretax (favorable) unfavorable development: Medical Professional Liability $ 1 $ (7 ) Other Professional Liability and Management Liability (32 ) (9 ) Surety — — Warranty — 2 Other — (20 ) Total pretax (favorable) unfavorable development $ (31 ) $ (34 ) 2017 Favorable development in other professional liability and management liability was primarily due to favorable settlements on closed claims and lower than expected frequency of large losses related to professional liability in accident years 2011 through 2016. 2016 Favorable development for medical professional liability was due to lower than expected severity in accident years 2011 and prior. This was partially offset by unfavorable development in accident years 2012 and 2013 related to higher than expected large loss emergence and higher than expected severity in accident years 2014 and 2015. Favorable development in other professional liability and management liability was primarily related to favorable settlements on claims in accident years 2011 through 2013. This was partially offset by unfavorable development related to a specific financial institutions claim in accident year 2014 and continued deterioration on claims in accident year 2009 related to the credit crisis. Favorable development for other coverages was primarily due to better than expected claim frequency in property coverages provided to Specialty customers in accident year 2015. Commercial The following table presents further detail of the development recorded for the Commercial segment. Three months ended March 31 (In millions) 2017 2016 Pretax (favorable) unfavorable development: Commercial Auto $ (26 ) $ (15 ) General Liability — (15 ) Workers' Compensation — 4 Property and Other 2 12 Total pretax (favorable) unfavorable development $ (24 ) $ (14 ) 2017 Favorable development for commercial auto was primarily due to lower than expected severity in accident years 2013 through 2015 . 2016 Favorable development for commercial auto was primarily due to favorable settlements on claims in accident years 2011 through 2014. Favorable development for general liability was primarily due to favorable settlements on claims in accident years 2013 and 2014. Unfavorable development for property and other was primarily due to higher than expected severity from a 2015 catastrophe event. International The following table presents further detail of the development recorded for the International segment. Three months ended March 31 (In millions) 2017 2016 Pretax (favorable) unfavorable development: Medical Professional Liability $ — $ — Other Professional Liability (1 ) (1 ) Liability — — Property & Marine 1 (4 ) Other (2 ) 1 Total pretax (favorable) unfavorable development $ (2 ) $ (4 ) Reserves In 2010, Continental Casualty Company (CCC) together with several of the Company’s insurance subsidiaries completed a transaction with National Indemnity Company (NICO), a subsidiary of Berkshire Hathaway Inc., under which substantially all of the Company’s legacy A&EP liabilities were ceded to NICO through a Loss Portfolio Transfer (LPT). At the effective date of the transaction, the Company ceded approximately $1.6 billion of net A&EP claim and allocated claim adjustment expense reserves to NICO under a retroactive reinsurance agreement with an aggregate limit of $4 billion . The $ 1.6 billion of claim and allocated claim adjustment expense reserves ceded to NICO was net of $1.2 billion of ceded claim and allocated claim adjustment expense reserves under existing third-party reinsurance contracts. The NICO LPT aggregate reinsurance limit also covers credit risk on the existing third-party reinsurance related to these liabilities. The Company paid NICO a reinsurance premium of $2 billion and transferred to NICO billed third-party reinsurance receivables related to A&EP claims with a net book value of $215 million , resulting in total consideration of $2.2 billion . Subsequent to the effective date of the LPT, the Company recognized adverse prior year development on its A&EP reserves which resulted in additional amounts ceded under the LPT. As a result, the cumulative amounts ceded under the LPT exceeded the $2.2 billion consideration paid, resulting in the NICO LPT moving into a gain position, requiring retroactive reinsurance accounting. Under retroactive reinsurance accounting, this gain is deferred and only recognized in earnings in proportion to actual paid recoveries under the LPT. Over the life of the contract, there is no economic impact as long as any additional losses incurred are within the limit of the LPT. In a period in which the Company recognizes a change in the estimate of A&EP reserves that increases the amounts ceded under the LPT, the proportion of actual paid recoveries to total ceded losses is impacted and the change in the deferred gain is recognized in earnings as if the revised estimate of ceded losses was available at the effective date of the LPT. The effect of the deferred retroactive reinsurance benefit is recorded in Insurance claims and policyholders' benefits in the Condensed Consolidated Statement of Operations. The following table presents the impact of the Loss Portfolio Transfer on the Condensed Consolidated Statements of Operations. Three months ended March 31 (In millions) 2017 2016 Net A&EP adverse development before consideration of LPT $ 60 $ 200 Retroactive reinsurance benefit recognized (40 ) (73 ) Pretax impact of A&EP reserve development and the LPT $ 20 $ 127 Based upon the Company's annual A&EP reserve review, net unfavorable prior year development of $60 million and $200 million was recognized before consideration of cessions to the LPT for the three months ended March 31, 2017 and 2016 . The 2017 unfavorable development was driven by modestly higher anticipated payouts on claims from known sources of asbestos exposure. The 2016 unfavorable development was driven by an increase in anticipated future expenses associated with determination of coverage, higher anticipated payouts associated with a limited number of historical accounts having significant asbestos exposures and higher than expected severity on pollution claims. While this unfavorable development was ceded to NICO under the LPT, the Company’s Net income in both periods was negatively affected due to the application of retroactive reinsurance accounting. As of March 31, 2017 and December 31, 2016 , the cumulative amounts ceded under the LPT were $2.9 billion and $2.8 billion . The unrecognized deferred retroactive reinsurance benefit was $354 million and $334 million as of March 31, 2017 and December 31, 2016 . NICO established a collateral trust account as security for its obligations to the Company. The fair value of the collateral trust account was $2.7 billion and $2.8 billion as of March 31, 2017 and December 31, 2016 . In addition, Berkshire Hathaway Inc. guaranteed the payment obligations of NICO up to the aggregate reinsurance limit as well as certain of NICO’s performance obligations under the trust agreement. NICO is responsible for claims handling and billing and collection from third-party reinsurers related to the Company’s A&EP claims. |
Legal Proceedings and Guarantee
Legal Proceedings and Guarantees | 3 Months Ended |
Mar. 31, 2017 | |
Legal Proceedings, Commitments and Contingencies, and Guarantees [Abstract] | |
Legal Proceedings and Guarantees | Legal Proceedings and Guarantees CNA 401(k) Plus Plan Litigation In September 2016, a class action lawsuit was filed against CCC, Continental Assurance Company (CAC), CNAF, the Investment Committee of the CNA 401(k) Plus Plan, The Northern Trust Company and John Does 1-10 (collectively Defendants) over the CNA 401(k) Plus Plan. The complaint alleges that Defendants breached fiduciary duties to the CNA 401(k) Plus Plan and caused prohibited transactions in violation of the Employee Retirement Income Security Act of 1974 when the CNA 401(k) Plus Plan's Fixed Income Fund’s annuity contract with CAC was canceled. The plaintiff alleges he and a proposed class of the CNA 401(k) Plus Plan participants who had invested in the Fixed Income Fund suffered lower returns in their CNA 401(k) Plus Plan investments as a consequence of these alleged violations and seeks relief on behalf of the putative class. This litigation is in its preliminary stages, and as of yet no class has been certified. CCC and the other defendants are contesting the case and management currently is unable to predict the final outcome or the impact on the Company’s financial condition, results of operations, or cash flows. As of March 31, 2017 , the likelihood of loss is reasonably possible, but the amount of loss, if any, cannot be estimated at this stage of the litigation. Small Business Premium Rate Adjustment The Company identified rating errors related to its multi-peril package product within its Small Business unit in the fourth quarter of 2016 and recorded a charge which reduced Earned premium by $16 million in anticipation of voluntarily issuing premium refunds related to affected policies written from December 1, 2015. The Company notified state regulators and provided them with details regarding these anticipated voluntary premium refunds and other corrective actions related to the multi-peril package product. At that time, the Company also alerted regulators that it was reviewing other business lines to determine whether similar issues exist. In the first quarter of 2017, the Company concluded its review and determined that there were also rating errors related to Small Business workers' compensation policies. Accordingly, the Company recorded a charge which reduced Earned premium by $42 million in anticipation of voluntarily issuing premium refunds related to affected policies written from March 1, 2014. The Company is currently in dialogue with state regulators regarding this matter. The estimated refund liability for the multi-peril product and workers' compensations policies as of March 31, 2017 was $36 million and $50 million , respectively. In the first quarter of 2017, the Company also recorded a $5 million liability for interest due to policyholders on the aggregate refund amounts. Any fines or penalties related to the foregoing are reasonably possible, but are not expected to be material to the Company's Condensed Consolidated Financial Statements. The amount of the refund and corresponding liability will continue to increase until required changes to the automated rating processes are fully implemented. The changes are expected to be implemented by the end of May for the multi-peril product and by the end of September for workers' compensation policies. Accordingly, subsequent to the periods discussed in the preceding paragraphs, written and earned premium for the subject product and policy lines are reported net of any impact from the premium rate adjustments. Other Litigation The Company is a party to other routine litigation incidental to its business, which, based on the facts and circumstances currently known, is not material to the Condensed Consolidated Financial Statements. Guarantees As of March 31, 2017 and December 31, 2016 , the Company had recorded liabilities of approximately $5 million related to guarantee and indemnification agreements. Management believes that it is not likely that any future indemnity claims will be significantly greater than the amounts recorded. In the course of selling business entities and assets to third parties, the Company agreed to guarantee the performance of certain obligations of previously owned subsidiaries and to indemnify purchasers for losses arising out of breaches of representations and warranties with respect to the business entities or assets sold, including, in certain cases, losses arising from undisclosed liabilities or certain named litigation. Such guarantee and indemnification agreements in effect for sales of business entities, assets and third-party loans may include provisions that survive indefinitely. As of March 31, 2017 , the aggregate amount related to quantifiable guarantees was $434 million and the aggregate amount related to quantifiable indemnification agreements was $254 million . In certain cases, should the Company be required to make payments under any such guarantee, it would have the right to seek reimbursement from an affiliate of a previously owned subsidiary. In addition, the Company has agreed to provide indemnification to third-party purchasers for certain losses associated with sold business entities or assets that are not limited by a contractual monetary amount. As of March 31, 2017 , the Company had outstanding unlimited indemnifications in connection with the sales of certain of its business entities or assets that included tax liabilities arising prior to a purchaser's ownership of an entity or asset, defects in title at the time of sale, employee claims arising prior to closing and in some cases losses arising from certain litigation and undisclosed liabilities. Certain provisions of the indemnification agreements survive indefinitely, while others survive until the applicable statutes of limitation expire, or until the agreed-upon contract terms expire. The Company also provided guarantees, if the primary obligor fails to perform, to holders of structured settlement annuities provided by a previously owned subsidiary. As of March 31, 2017 , the potential amount of future payments the Company could be required to pay under these guarantees was approximately $1.8 billion , which will be paid over the lifetime of the annuitants. The Company does not believe any payment is likely under these guarantees, as the Company is the beneficiary of a trust that must be maintained at a level that approximates the discounted reserves for these annuities. |
Benefit Plans
Benefit Plans | 3 Months Ended |
Mar. 31, 2017 | |
Compensation and Retirement Disclosure [Abstract] | |
Benefit Plans | Benefit Plans The components of net periodic cost (benefit) are presented in the following table. Three months ended March 31 (In millions) 2017 2016 Pension cost (benefit) Interest cost on projected benefit obligation $ 26 $ 28 Expected return on plan assets (39 ) (40 ) Amortization of net actuarial loss 9 9 Settlement loss 2 — Net periodic pension cost (benefit) $ (2 ) $ (3 ) |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income (Loss) by Component | 3 Months Ended |
Mar. 31, 2017 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Accumulated Other Comprehensive Income (Loss) by Component | Accumulated Other Comprehensive Income (Loss) by Component The tables below display the changes in Accumulated other comprehensive income (loss) by component. (In millions) Net unrealized gains (losses) on investments with OTTI losses Net unrealized gains (losses) on other investments Pension and postretirement benefits Cumulative foreign currency translation adjustment Total Balance as of January 1, 2017 $ 30 $ 642 $ (647 ) $ (198 ) $ (173 ) Other comprehensive income (loss) before reclassifications — 85 — 11 96 Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $(2), $(9), $4, $- and $(7) 4 18 (7 ) — 15 Other comprehensive income (loss) net of tax (expense) benefit of $1, $(38), $(4), $- and $(41) (4 ) 67 7 11 81 Balance as of March 31, 2017 $ 26 $ 709 $ (640 ) $ (187 ) $ (92 ) (In millions) Net unrealized gains (losses) on investments with OTTI losses Net unrealized gains (losses) on other investments Pension and postretirement benefits Cumulative foreign currency translation adjustment Total Balance as of January 1, 2016 $ 27 $ 390 $ (648 ) $ (84 ) $ (315 ) Other comprehensive income (loss) before reclassifications 3 223 — 14 240 Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $1, $7, $3, $- and $11 (2 ) (11 ) (6 ) — (19 ) Other comprehensive income (loss) net of tax (expense) benefit of $(3), $(116), $(3), $- and $(122) 5 234 6 14 259 Balance as of March 31, 2016 $ 32 $ 624 $ (642 ) $ (70 ) $ (56 ) Amounts reclassified from Accumulated other comprehensive income (loss) shown above are reported in Net income (loss) as follows: Component of AOCI Condensed Consolidated Statements of Operations Line Item Affected by Reclassifications Net unrealized gains (losses) on investments with OTTI losses Net realized investment gains (losses) Net unrealized gains (losses) on other investments Net realized investment gains (losses) Pension and postretirement benefits Other operating expenses |
Business Segments
Business Segments | 3 Months Ended |
Mar. 31, 2017 | |
Segment Reporting [Abstract] | |
Business Segments | Business Segments The Company's core property and casualty commercial insurance operations are managed and reported in three business segments: Specialty, Commercial and International. The Company's non-core operations are managed and reported in two segments: Life & Group Non-Core and Corporate & Other Non-Core. The accounting policies of the segments are the same as those described in Note A to the Consolidated Financial Statements within CNAF's Annual Report on Form 10-K for the year ended December 31, 2016 . The Company manages most of its assets on a legal entity basis, while segment operations are generally conducted across legal entities. As such, only Insurance and Reinsurance receivables, Insurance reserves, Deferred acquisition costs and Goodwill are readily identifiable for all individual segments. Distinct investment portfolios are not maintained for every individual segment; accordingly, allocation of assets to each segment is not performed. Therefore, a significant portion of Net investment income and Realized investment gains or losses are allocated primarily based on each segment's net carried insurance reserves, as adjusted. All significant intersegment income and expense has been eliminated. Income taxes have been allocated on the basis of the taxable income of the segments. In the following tables, certain financial measures are presented to provide information used by management to monitor the Company's operating performance. Management utilizes these financial measures to monitor the Company's insurance operations and investment portfolio. Net operating income (loss), which is derived from certain income statement amounts, is used by management to monitor performance of the Company's insurance operations. The Company's investment portfolio is monitored by management through analysis of various factors including unrealized gains and losses on securities, portfolio duration and exposure to market and credit risk. Based on such analyses, the Company may recognize an OTTI loss on an investment security in accordance with its policy, or sell a security, which may produce realized gains and losses. Net operating income (loss) is calculated by excluding from net income (loss) the after-tax effects of i) net realized investment gains (losses) ii) income or loss from discontinued operations and iii) any cumulative effects of changes in accounting guidance. The calculation of net operating income excludes net realized investment gains (losses) because net realized investment gains (losses) are largely discretionary, except for some losses related to OTTI, and are generally driven by economic factors that are not necessarily consistent with key drivers of underwriting performance, and are therefore not considered an indication of trends in insurance operations. The Company's results of operations and selected balance sheet items by segment are presented in the following tables. Three months ended March 31, 2017 Specialty Commercial International Life & Group Non-Core Corporate & Other Non-Core (In millions) Eliminations Total Operating revenues Net earned premiums $ 664 $ 651 $ 197 $ 133 $ — $ — $ 1,645 Net investment income 153 178 12 197 5 — 545 Other revenues 94 9 — 1 — — 104 Total operating revenues 911 838 209 331 5 — 2,294 Claims, Benefits and Expenses Net incurred claims and benefits 386 437 115 330 21 — 1,289 Policyholders’ dividends 1 3 — — — — 4 Amortization of deferred acquisition costs 143 116 46 — — — 305 Other insurance related expenses 69 126 27 32 — — 254 Other expenses 81 14 (6 ) 2 44 — 135 Total claims, benefits and expenses 680 696 182 364 65 — 1,987 Operating income (loss) before income tax 231 142 27 (33 ) (60 ) — 307 Income tax (expense) benefit on operating income (loss) (77 ) (48 ) (7 ) 37 23 — (72 ) Net operating income (loss) 154 94 20 4 (37 ) — 235 Net realized investment gains (losses) 7 11 6 10 2 — 36 Income tax (expense) benefit on net realized investment gains (losses) (3 ) (3 ) (1 ) (4 ) — — (11 ) Net realized investment gains (losses), after tax 4 8 5 6 2 — 25 Net income (loss) $ 158 $ 102 $ 25 $ 10 $ (35 ) $ — $ 260 March 31, 2017 (In millions) Reinsurance receivables $ 817 $ 616 $ 133 $ 448 $ 2,419 $ — $ 4,433 Insurance receivables 874 1,048 254 12 3 — 2,191 Deferred acquisition costs 314 225 87 — — — 626 Goodwill 117 — 29 — — — 146 Insurance reserves Claim and claim adjustment expenses 6,224 8,760 1,343 3,373 2,560 — 22,260 Unearned premiums 1,941 1,375 450 147 — (1 ) 3,912 Future policy benefits — — — 10,491 — — 10,491 Three months ended March 31, 2016 Specialty Commercial International Life & Group Non-Core Corporate & Other Non-Core (In millions) Eliminations Total Operating revenues Net earned premiums $ 682 $ 688 $ 198 $ 131 $ — $ — $ 1,699 Net investment income 107 126 12 187 3 — 435 Other revenues 87 6 1 — 3 — 97 Total operating revenues 876 820 211 318 6 — 2,231 Claims, Benefits and Expenses Net incurred claims and benefits 390 442 121 323 128 — 1,404 Policyholders’ dividends 1 3 — — — — 4 Amortization of deferred acquisition costs 144 116 47 — — — 307 Other insurance related expenses 75 141 28 33 — — 277 Other expenses 75 5 9 3 54 — 146 Total claims, benefits and expenses 685 707 205 359 182 — 2,138 Operating income (loss) before income tax 191 113 6 (41 ) (176 ) — 93 Income tax (expense) benefit on operating income (loss) (64 ) (39 ) — 39 62 — (2 ) Net operating income (loss) 127 74 6 (2 ) (114 ) — 91 Net realized investment gains (losses) (11 ) (18 ) 4 (3 ) (8 ) — (36 ) Income tax (expense) benefit on net realized investment gains (losses) 4 6 (1 ) — 2 — 11 Net realized investment gains (losses), after tax (7 ) (12 ) 3 (3 ) (6 ) — (25 ) Net income (loss) $ 120 $ 62 $ 9 $ (5 ) $ (120 ) $ — $ 66 March 31, 2016 (In millions) Reinsurance receivables $ 765 $ 623 $ 139 $ 496 $ 2,707 $ — $ 4,730 Insurance receivables 884 1,025 276 14 2 — 2,201 Deferred acquisition costs 309 225 88 — — — 622 Goodwill 117 — 33 — — — 150 Insurance reserves Claim and claim adjustment expenses 6,325 9,095 1,395 3,311 2,892 — 23,018 Unearned premiums 1,861 1,347 464 136 — (1 ) 3,807 Future policy benefits — — — 10,500 — — 10,500 The following table presents revenue by line of business for each reportable segment. Revenues are comprised of operating revenues and net realized investment gains and losses. Three months ended March 31 (In millions) 2017 2016 Specialty Management & Professional Liability $ 661 $ 618 Surety 123 127 Warranty & Alternative Risks 134 120 Specialty revenues 918 865 Commercial Middle Market 458 401 Small Business 97 143 Other Commercial Insurance 294 258 Commercial revenues 849 802 International Canada 51 50 CNA Europe 73 78 Hardy 91 87 International revenues 215 215 Life & Group Non-Core revenues 341 315 Corporate & Other Non-Core revenues 7 (2 ) Eliminations — — Total revenues $ 2,330 $ 2,195 |
General (Policies)
General (Policies) | 3 Months Ended |
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
Consolidation | The accompanying Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). Intercompany amounts have been eliminated. Certain financial information that is normally included in annual financial statements prepared in accordance with GAAP, including certain financial statement notes, is not required for interim reporting purposes and has been condensed or omitted. These statements should be read in conjunction with the Consolidated Financial Statements and notes thereto included in CNAF's Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended December 31, 2016 , including the summary of significant accounting policies in Note A. |
Use of Estimates | The preparation of Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. |
Recently Adopted Accounting Standards Updates and Accounting Standards Pending Adoption | Recently Adopted Accounting Standards Updates (ASU) In March 2016, the Financial Accounting Standards Board (FASB) issued ASU No. 2016-09, Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The updated accounting guidance simplifies the accounting for share-based payment award transactions, including income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. As of January 1, 2017, the Company adopted the updated accounting guidance and began recognizing excess tax benefits or deficiencies on vesting or settlement of awards as an income tax benefit or expense within net income, instead of additional paid-in capital as required under previous guidance. The related cash flows are now classified within operating activities. As a result of this change, excess tax benefits are no longer included in assumed proceeds under the treasury stock method of calculating earnings per share. The impact of the accounting change resulted in a decrease of $3 million to income tax expense for the three months ended March 31, 2017. Accounting Standards Pending Adoption In May 2014, the FASB issued ASU No. 2014-09, Revenue Recognition (Topic 606): Revenue from Contracts with Customers . The standard excludes from its scope the accounting for insurance contracts, financial instruments, and certain other agreements that are governed under other GAAP guidance. The updated guidance requires an entity to recognize revenue as performance obligations are met, in an amount that reflects the consideration the entity is entitled to receive for the transfer of the promised goods or services. The standard is effective for interim and annual reporting periods beginning after December 15, 2017 and may be applied retrospectively or through a cumulative effect adjustment to retained earnings at the date of adoption. As insurance contracts are out of scope, the Company anticipates the primary change will be to revenue recognition for certain of our warranty products and services. The Company has not made a decision on the method of adoption and is currently evaluating the effect the updated guidance will have on the Company’s financial statements, but we do not currently believe ASU 2014-09 will have a material effect on the Company's results of operations or financial position. In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The updated accounting guidance requires changes to the reporting model for financial instruments. The guidance is effective for interim and annual periods beginning after December 15, 2017. The Company is currently evaluating the effect the guidance will have on the Company's financial statements, and expects the primary change for the Company to be the requirement for equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842): Accounting for Leases. The updated accounting guidance requires lessees to recognize on the balance sheet the assets and liabilities for the rights and obligations created by all leases, including those historically accounted for as operating leases. The guidance is effective for interim and annual periods beginning after December 15, 2018. The Company is currently evaluating the effect the updated guidance will have on the Company's financial statements. It is expected that assets and liabilities will increase based on the present value of remaining lease payments for leases in place at the adoption date; however, this is not expected to be material to the Company's results of operations or financial position. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The updated accounting guidance requires changes to the recognition of credit losses on financial instruments not accounted for at fair value through net income. The guidance is effective for interim and annual periods beginning after December 15, 2019. The Company is currently evaluating the effect the guidance will have on the Company's financial statements, but expects the primary changes to be the use of the expected credit loss model for its mortgage loan portfolio and reinsurance receivables and the presentation of credit losses within the available-for-sale fixed maturities portfolio through an allowance method rather than as a direct write-down. The expected credit loss model will require a financial asset to be presented at the net amount expected to be collected. The allowance method for available-for-sale debt securities will allow the Company to record reversals of credit losses if the estimate of credit losses declines. In March 2017, the FASB issued ASU No. 2017-07, Compensation-Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost . The updated accounting guidance requires changes to the presentation of the components of net periodic benefit cost on the income statement by requiring service cost to be presented with other employee compensation costs and other components of net periodic pension cost to be presented outside of any subtotal of operating income. The ASU also stipulates that only the service cost component of net benefit cost is eligible for capitalization. The guidance is effective for interim and annual periods beginning after December 15, 2017. The Company is currently evaluating the effect the guidance will have on the Company's financial statements. |
Investments (Tables)
Investments (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Investments [Abstract] | |
Net investment income | The significant components of Net investment income are presented in the following table. Three months ended March 31 (In millions) 2017 2016 Fixed maturity securities $ 455 $ 446 Equity securities 1 3 Limited partnership investments 90 (14 ) Mortgage loans 7 9 Short term investments 3 3 Trading portfolio 2 2 Other 1 — Gross investment income 559 449 Investment expense (14 ) (14 ) Net investment income $ 545 $ 435 |
Net realized investment gains (losses) | Net realized investment gains (losses) are presented in the following table. Three months ended March 31 (In millions) 2017 2016 Net realized investment gains (losses): Fixed maturity securities: Gross realized gains $ 49 $ 45 Gross realized losses (17 ) (62 ) Net realized investment gains (losses) on fixed maturity securities 32 (17 ) Equity securities: Gross realized gains — — Gross realized losses — (5 ) Net realized investment gains (losses) on equity securities — (5 ) Derivatives 1 (7 ) Short term investments and other 3 (7 ) Net realized investment gains (losses) $ 36 $ (36 ) |
Components of net other than temporary impairment losses recognized in earnings by asset type | The components of Other-than-temporary impairment (OTTI) losses recognized in earnings by asset type are presented in the following table. Three months ended March 31 (In millions) 2017 2016 Fixed maturity securities available-for-sale: Corporate and other bonds $ 2 $ 16 Asset-backed: Residential mortgage-backed — — Other asset-backed — 2 Total asset-backed — 2 Total fixed maturity securities available-for-sale 2 18 Equity securities available-for-sale -- Common stock — 5 OTTI losses recognized in earnings $ 2 $ 23 |
Summary of fixed maturity and equity securities | The following tables present a summary of fixed maturity and equity securities. March 31, 2017 Cost or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Unrealized OTTI Losses (Gains) (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 17,838 $ 1,428 $ 37 $ 19,229 $ (1 ) States, municipalities and political subdivisions 12,261 1,219 31 13,449 (12 ) Asset-backed: Residential mortgage-backed 4,672 121 50 4,743 (27 ) Commercial mortgage-backed 1,902 52 19 1,935 — Other asset-backed 1,043 10 4 1,049 — Total asset-backed 7,617 183 73 7,727 (27 ) U.S. Treasury and obligations of government-sponsored enterprises 95 8 — 103 — Foreign government 419 14 1 432 — Redeemable preferred stock 19 1 — 20 — Total fixed maturity securities available-for-sale 38,249 2,853 142 40,960 $ (40 ) Total fixed maturity securities trading 20 20 Equity securities available-for-sale: Common stock 20 5 — 25 Preferred stock 92 5 2 95 Total equity securities available-for-sale 112 10 2 120 Total $ 38,381 $ 2,863 $ 144 $ 41,100 December 31, 2016 Cost or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Unrealized OTTI Losses (Gains) (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 17,711 $ 1,323 $ 76 $ 18,958 $ (1 ) States, municipalities and political subdivisions 12,060 1,213 33 13,240 (16 ) Asset-backed: Residential mortgage-backed 5,004 120 51 5,073 (28 ) Commercial mortgage-backed 2,016 48 24 2,040 — Other asset-backed 1,022 8 5 1,025 — Total asset-backed 8,042 176 80 8,138 (28 ) U.S. Treasury and obligations of government-sponsored enterprises 83 10 — 93 — Foreign government 435 13 3 445 — Redeemable preferred stock 18 1 — 19 — Total fixed maturity securities available-for-sale 38,349 2,736 192 40,893 $ (45 ) Total fixed maturity securities trading 12 12 Equity securities available-for-sale: Common stock 13 6 — 19 Preferred stock 93 2 4 91 Total equity securities available-for-sale 106 8 4 110 Total $ 38,467 $ 2,744 $ 196 $ 41,015 |
Securities in a gross unrealized loss position | The following tables present the estimated fair value and gross unrealized losses of fixed maturity and equity securities in a gross unrealized loss position by the length of time in which the securities have continuously been in that position. Less than 12 Months 12 Months or Longer Total March 31, 2017 Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 1,915 $ 29 $ 134 $ 8 $ 2,049 $ 37 States, municipalities and political subdivisions 845 31 33 — 878 31 Asset-backed: Residential mortgage-backed 2,188 44 170 6 2,358 50 Commercial mortgage-backed 590 15 139 4 729 19 Other asset-backed 256 4 28 — 284 4 Total asset-backed 3,034 63 337 10 3,371 73 U.S. Treasury and obligations of government-sponsored enterprises 31 — — — 31 — Foreign government 89 1 — — 89 1 Total fixed maturity securities available-for-sale 5,914 124 504 18 6,418 142 Equity securities available-for-sale: Common stock 2 — — — 2 — Preferred stock 15 2 — — 15 2 Total equity securities available-for-sale 17 2 — — 17 2 Total $ 5,931 $ 126 $ 504 $ 18 $ 6,435 $ 144 Less than 12 Months 12 Months or Longer Total December 31, 2016 Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 2,615 $ 61 $ 254 $ 15 $ 2,869 $ 76 States, municipalities and political subdivisions 959 32 23 1 982 33 Asset-backed: Residential mortgage-backed 2,136 44 201 7 2,337 51 Commercial mortgage-backed 756 22 69 2 825 24 Other asset-backed 398 5 24 — 422 5 Total asset-backed 3,290 71 294 9 3,584 80 U.S. Treasury and obligations of government-sponsored enterprises 5 — — — 5 — Foreign government 108 3 — — 108 3 Total fixed maturity securities available-for-sale 6,977 167 571 25 7,548 192 Equity securities available-for-sale -- Preferred stock 12 — 13 4 25 4 Total $ 6,989 $ 167 $ 584 $ 29 $ 7,573 $ 196 |
Activity related to the pretax fixed maturity credit loss component reflected within retained earnings for securities still held for which a portion of an OTTI loss was recognized in OCI | The following table presents the activity related to the pretax credit loss component reflected in Retained earnings on fixed maturity securities still held as of March 31, 2017 and 2016 for which a portion of an OTTI loss was recognized in Other comprehensive income (loss). Three months ended March 31 (In millions) 2017 2016 Beginning balance of credit losses on fixed maturity securities $ 36 $ 53 Reductions for securities sold during the period (4 ) (5 ) Ending balance of credit losses on fixed maturity securities $ 32 $ 48 |
Contractual maturity | The following table presents available-for-sale fixed maturity securities by contractual maturity. March 31, 2017 December 31, 2016 (In millions) Cost or Amortized Cost Estimated Fair Value Cost or Amortized Cost Estimated Fair Value Due in one year or less $ 1,655 $ 1,701 $ 1,779 $ 1,828 Due after one year through five years 7,539 7,918 7,566 7,955 Due after five years through ten years 15,645 16,176 15,892 16,332 Due after ten years 13,410 15,165 13,112 14,778 Total $ 38,249 $ 40,960 $ 38,349 $ 40,893 |
Fair Value (Tables)
Fair Value (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Assets and liabilities measured at fair value on a recurring basis | Assets and liabilities measured at fair value on a recurring basis are presented in the following tables. March 31, 2017 Total Assets/Liabilities at Fair Value (In millions) Level 1 Level 2 Level 3 Assets Fixed maturity securities: Corporate and other bonds $ — $ 19,125 $ 121 $ 19,246 States, municipalities and political subdivisions — 13,451 1 13,452 Asset-backed: Residential mortgage-backed — 4,617 126 4,743 Commercial mortgage-backed — 1,922 13 1,935 Other asset-backed — 932 117 1,049 Total asset-backed — 7,471 256 7,727 U.S. Treasury and obligations of government-sponsored enterprises 103 — — 103 Foreign government — 432 — 432 Redeemable preferred stock 20 — — 20 Total fixed maturity securities 123 40,479 378 40,980 Equity securities 101 — 19 120 Other invested assets — 5 — 5 Short term investments 225 829 — 1,054 Life settlement contracts, included in Other assets — — 46 46 Total assets $ 449 $ 41,313 $ 443 $ 42,205 Liabilities Other liabilities $ — $ (2 ) $ — $ (2 ) Total liabilities $ — $ (2 ) $ — $ (2 ) December 31, 2016 Total Assets/Liabilities at Fair Value (In millions) Level 1 Level 2 Level 3 Assets Fixed maturity securities: Corporate and other bonds $ — $ 18,840 $ 130 $ 18,970 States, municipalities and political subdivisions — 13,239 1 13,240 Asset-backed: Residential mortgage-backed — 4,944 129 5,073 Commercial mortgage-backed — 2,027 13 2,040 Other asset-backed — 968 57 1,025 Total asset-backed — 7,939 199 8,138 U.S. Treasury and obligations of government-sponsored enterprises 93 — — 93 Foreign government — 445 — 445 Redeemable preferred stock 19 — — 19 Total fixed maturity securities 112 40,463 330 40,905 Equity securities 91 — 19 110 Other invested assets — 5 — 5 Short term investments 475 853 — 1,328 Life settlement contracts, included in Other assets — — 58 58 Total assets $ 678 $ 41,321 $ 407 $ 42,406 Liabilities Other liabilities $ — $ (3 ) $ — $ (3 ) Total liabilities $ — $ (3 ) $ — $ (3 ) |
Table of reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs | The tables below present a reconciliation for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3). Level 3 (In millions) Balance as of January 1, 2017 Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)* Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) Purchases Sales Settlements Transfers into Level 3 Transfers out of Level 3 Balance as of March 31, 2017 Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss)* Fixed maturity securities: Corporate and other bonds $ 130 $ — $ 1 $ 5 $ (1 ) $ (14 ) $ — $ — $ 121 $ — States, municipalities and political subdivisions 1 — — — — — — — 1 — Asset-backed: Residential mortgage-backed 129 1 2 — — (6 ) — — 126 — Commercial mortgage-backed 13 — — — — — — — 13 — Other asset-backed 57 (1 ) — 38 — — 28 (5 ) 117 — Total asset-backed 199 — 2 38 — (6 ) 28 (5 ) 256 — Total fixed maturity securities 330 — 3 43 (1 ) (20 ) 28 (5 ) 378 — Equity securities 19 — 1 1 (2 ) — — — 19 — Derivative financial instruments — 1 — — (1 ) — — — — — Life settlement contracts 58 6 — — (13 ) (5 ) — — 46 — Total $ 407 $ 7 $ 4 $ 44 $ (17 ) $ (25 ) $ 28 $ (5 ) $ 443 $ — Level 3 (In millions) Balance as of January 1, 2016 Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)* Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) Purchases Sales Settlements Transfers into Level 3 Transfers out of Level 3 Balance as of March 31, 2016 Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2016 recognized in Net income (loss)* Fixed maturity securities: Corporate and other bonds $ 168 $ (1 ) $ 4 $ 53 $ (16 ) $ (3 ) $ — $ (12 ) $ 193 $ — States, municipalities and political subdivisions 2 — — — — — — — 2 — Asset-backed: Residential mortgage-backed 134 1 — — — (5 ) — (2 ) 128 — Commercial mortgage-backed 22 — — 9 — — — (4 ) 27 — Other asset-backed 53 — — — — — 2 (5 ) 50 — Total asset-backed 209 1 — 9 — (5 ) 2 (11 ) 205 — Total fixed maturity securities 379 — 4 62 (16 ) (8 ) 2 (23 ) 400 — Equity securities 20 — (1 ) — — — — — 19 — Life settlement contracts 74 4 — — — (6 ) — — 72 1 Total $ 473 $ 4 $ 3 $ 62 $ (16 ) $ (14 ) $ 2 $ (23 ) $ 491 $ 1 *Net realized and unrealized gains and losses from Level 3 securities and derivatives are reported in Net income (loss) as follows: Major Category of Assets and Liabilities Condensed Consolidated Statements of Operations Line Items Fixed maturity securities available-for-sale (1) Net realized investment gains (losses) Fixed maturity securities trading Net investment income Equity securities (1) Net realized investment gains (losses) Other invested assets - Derivative financial instruments held in a trading portfolio Net investment income Other invested assets - Derivative financial instruments not held in a trading portfolio Net realized investment gains (losses) Life settlement contracts Other revenues Other liabilities - Derivative financial instruments Net realized investment gains (losses) (1) Unrealized gains and losses are reported within AOCI. |
Qualitative information about assets and liabilities | *Net realized and unrealized gains and losses from Level 3 securities and derivatives are reported in Net income (loss) as follows: Major Category of Assets and Liabilities Condensed Consolidated Statements of Operations Line Items Fixed maturity securities available-for-sale (1) Net realized investment gains (losses) Fixed maturity securities trading Net investment income Equity securities (1) Net realized investment gains (losses) Other invested assets - Derivative financial instruments held in a trading portfolio Net investment income Other invested assets - Derivative financial instruments not held in a trading portfolio Net realized investment gains (losses) Life settlement contracts Other revenues Other liabilities - Derivative financial instruments Net realized investment gains (losses) (1) Unrealized gains and losses are reported within AOCI. |
Quantitative information about significant unobservable inputs in the fair value measurement of level 3 assets | The following tables present quantitative information about the significant unobservable inputs utilized by the Company in the fair value measurements of Level 3 assets. Valuations for assets and liabilities not presented in the tables below are primarily based on broker/dealer quotes for which there is a lack of transparency as to inputs used to develop the valuations. The quantitative detail of these unobservable inputs is neither provided nor reasonably available to the Company. The valuation of life settlement contracts was based on the terms of the sale of the contracts to a third party, therefore, the contracts are not included in the table below. March 31, 2017 Estimated Fair Value (In millions) Valuation Technique(s) Unobservable Input(s) Range (Weighted Average) Fixed maturity securities $ 122 Discounted cash flow Credit spread 2% - 40% (4%) December 31, 2016 Estimated Fair Value Valuation Technique(s) Unobservable Input(s) Range (Weighted Average) Fixed maturity securities $ 106 Discounted cash flow Credit spread 2% - 40% (4%) |
Carrying amount and estimated fair value of financial instrument assets and liabilities not measured at fair value | The carrying amount and estimated fair value of the Company's financial assets and liabilities which are not measured at fair value on the Condensed Consolidated Balance Sheets are presented in the following tables. March 31, 2017 Carrying Amount Estimated Fair Value (In millions) Level 1 Level 2 Level 3 Total Assets Mortgage loans $ 611 $ — $ — $ 616 $ 616 Note receivable 10 — — 10 10 Liabilities Short term debt $ 150 $ — $ 156 $ — $ 156 Long term debt 2,560 — 2,811 — 2,811 December 31, 2016 Carrying Estimated Fair Value (In millions) Level 1 Level 2 Level 3 Total Assets Mortgage loans $ 591 $ — $ — $ 594 $ 594 Liabilities Long term debt $ 2,710 $ — $ 2,952 $ — $ 2,952 |
Claim and Claim Adjustment Ex20
Claim and Claim Adjustment Expense Reserves (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Liability for Claims and Claims Adjustment Expense [Line Items] | |
Schedule of liability for unpaid claims and claims adjustment expense | The following table presents a reconciliation between beginning and ending claim and claim adjustment expense reserves, including claim and claim adjustment expense reserves of the Life & Group Non-Core segment. For the three months ended March 31 (In millions) 2017 2016 Reserves, beginning of year: Gross $ 22,343 $ 22,663 Ceded 4,094 4,087 Net reserves, beginning of year 18,249 18,576 Net incurred claim and claim adjustment expenses: Provision for insured events of current year 1,207 1,224 Decrease in provision for insured events of prior years (82 ) (45 ) Amortization of discount 48 48 Total net incurred (1) 1,173 1,227 Net payments attributable to: Current year events (68 ) (76 ) Prior year events (1,184 ) (1,147 ) Total net payments (1,252 ) (1,223 ) Foreign currency translation adjustment and other 14 39 Net reserves, end of period 18,184 18,619 Ceded reserves, end of period 4,076 4,399 Gross reserves, end of period $ 22,260 $ 23,018 (1) Total net incurred above does not agree to Insurance claims and policyholders' benefits as reflected on the Condensed Consolidated Statements of Operations due to amounts related to retroactive reinsurance deferred gain accounting, uncollectible reinsurance and loss deductible receivables, and benefit expenses related to future policy benefits, which are not reflected in the table above. |
Net prior year development | The following tables and discussion present the net prior year development recorded for Specialty, Commercial, International and Corporate & Other Non-Core segments. Three months ended March 31, 2017 (In millions) Specialty Commercial International Corporate & Other Non-Core Total Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development $ (31 ) $ (24 ) $ (2 ) $ — $ (57 ) Pretax (favorable) unfavorable premium development (5 ) 37 (7 ) — 25 Total pretax (favorable) unfavorable net prior year development $ (36 ) $ 13 $ (9 ) $ — $ (32 ) Three months ended March 31, 2016 (In millions) Specialty Commercial International Corporate & Other Non-Core Total Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development $ (34 ) $ (14 ) $ (4 ) $ — $ (52 ) Pretax (favorable) unfavorable premium development (11 ) (2 ) (1 ) — (14 ) Total pretax (favorable) unfavorable net prior year development $ (45 ) $ (16 ) $ (5 ) $ — $ (66 ) |
Specialty | |
Liability for Claims and Claims Adjustment Expense [Line Items] | |
Net prior year claim and allocated claim adjustment expense reserve development | The following table presents further detail of the net prior year claim and allocated claim adjustment expense reserve development (development) recorded for the Specialty segment. Three months ended March 31 (In millions) 2017 2016 Pretax (favorable) unfavorable development: Medical Professional Liability $ 1 $ (7 ) Other Professional Liability and Management Liability (32 ) (9 ) Surety — — Warranty — 2 Other — (20 ) Total pretax (favorable) unfavorable development $ (31 ) $ (34 ) |
Commercial | |
Liability for Claims and Claims Adjustment Expense [Line Items] | |
Net prior year claim and allocated claim adjustment expense reserve development | The following table presents further detail of the development recorded for the Commercial segment. Three months ended March 31 (In millions) 2017 2016 Pretax (favorable) unfavorable development: Commercial Auto $ (26 ) $ (15 ) General Liability — (15 ) Workers' Compensation — 4 Property and Other 2 12 Total pretax (favorable) unfavorable development $ (24 ) $ (14 ) |
International | |
Liability for Claims and Claims Adjustment Expense [Line Items] | |
Net prior year claim and allocated claim adjustment expense reserve development | The following table presents further detail of the development recorded for the International segment. Three months ended March 31 (In millions) 2017 2016 Pretax (favorable) unfavorable development: Medical Professional Liability $ — $ — Other Professional Liability (1 ) (1 ) Liability — — Property & Marine 1 (4 ) Other (2 ) 1 Total pretax (favorable) unfavorable development $ (2 ) $ (4 ) |
CNAF Consolidated | |
Liability for Claims and Claims Adjustment Expense [Line Items] | |
Impact of loss portfolio transfer on the consolidated statement of operations | The following table presents the impact of the Loss Portfolio Transfer on the Condensed Consolidated Statements of Operations. Three months ended March 31 (In millions) 2017 2016 Net A&EP adverse development before consideration of LPT $ 60 $ 200 Retroactive reinsurance benefit recognized (40 ) (73 ) Pretax impact of A&EP reserve development and the LPT $ 20 $ 127 |
Benefit Plans (Tables)
Benefit Plans (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Compensation and Retirement Disclosure [Abstract] | |
Components of net periodic cost (benefit) | The components of net periodic cost (benefit) are presented in the following table. Three months ended March 31 (In millions) 2017 2016 Pension cost (benefit) Interest cost on projected benefit obligation $ 26 $ 28 Expected return on plan assets (39 ) (40 ) Amortization of net actuarial loss 9 9 Settlement loss 2 — Net periodic pension cost (benefit) $ (2 ) $ (3 ) |
Accumulated Other Comprehensi22
Accumulated Other Comprehensive Income (Loss) by Component (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Accumulated other comprehensive income (loss) by component | The tables below display the changes in Accumulated other comprehensive income (loss) by component. (In millions) Net unrealized gains (losses) on investments with OTTI losses Net unrealized gains (losses) on other investments Pension and postretirement benefits Cumulative foreign currency translation adjustment Total Balance as of January 1, 2017 $ 30 $ 642 $ (647 ) $ (198 ) $ (173 ) Other comprehensive income (loss) before reclassifications — 85 — 11 96 Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $(2), $(9), $4, $- and $(7) 4 18 (7 ) — 15 Other comprehensive income (loss) net of tax (expense) benefit of $1, $(38), $(4), $- and $(41) (4 ) 67 7 11 81 Balance as of March 31, 2017 $ 26 $ 709 $ (640 ) $ (187 ) $ (92 ) (In millions) Net unrealized gains (losses) on investments with OTTI losses Net unrealized gains (losses) on other investments Pension and postretirement benefits Cumulative foreign currency translation adjustment Total Balance as of January 1, 2016 $ 27 $ 390 $ (648 ) $ (84 ) $ (315 ) Other comprehensive income (loss) before reclassifications 3 223 — 14 240 Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $1, $7, $3, $- and $11 (2 ) (11 ) (6 ) — (19 ) Other comprehensive income (loss) net of tax (expense) benefit of $(3), $(116), $(3), $- and $(122) 5 234 6 14 259 Balance as of March 31, 2016 $ 32 $ 624 $ (642 ) $ (70 ) $ (56 ) |
Reclassification out of accumulated other comprehensive income | Amounts reclassified from Accumulated other comprehensive income (loss) shown above are reported in Net income (loss) as follows: Component of AOCI Condensed Consolidated Statements of Operations Line Item Affected by Reclassifications Net unrealized gains (losses) on investments with OTTI losses Net realized investment gains (losses) Net unrealized gains (losses) on other investments Net realized investment gains (losses) Pension and postretirement benefits Other operating expenses |
Business Segments (Tables)
Business Segments (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Segment Reporting [Abstract] | |
Significant components of the Company's continuing operations and selected balance sheet items | The Company's results of operations and selected balance sheet items by segment are presented in the following tables. Three months ended March 31, 2017 Specialty Commercial International Life & Group Non-Core Corporate & Other Non-Core (In millions) Eliminations Total Operating revenues Net earned premiums $ 664 $ 651 $ 197 $ 133 $ — $ — $ 1,645 Net investment income 153 178 12 197 5 — 545 Other revenues 94 9 — 1 — — 104 Total operating revenues 911 838 209 331 5 — 2,294 Claims, Benefits and Expenses Net incurred claims and benefits 386 437 115 330 21 — 1,289 Policyholders’ dividends 1 3 — — — — 4 Amortization of deferred acquisition costs 143 116 46 — — — 305 Other insurance related expenses 69 126 27 32 — — 254 Other expenses 81 14 (6 ) 2 44 — 135 Total claims, benefits and expenses 680 696 182 364 65 — 1,987 Operating income (loss) before income tax 231 142 27 (33 ) (60 ) — 307 Income tax (expense) benefit on operating income (loss) (77 ) (48 ) (7 ) 37 23 — (72 ) Net operating income (loss) 154 94 20 4 (37 ) — 235 Net realized investment gains (losses) 7 11 6 10 2 — 36 Income tax (expense) benefit on net realized investment gains (losses) (3 ) (3 ) (1 ) (4 ) — — (11 ) Net realized investment gains (losses), after tax 4 8 5 6 2 — 25 Net income (loss) $ 158 $ 102 $ 25 $ 10 $ (35 ) $ — $ 260 March 31, 2017 (In millions) Reinsurance receivables $ 817 $ 616 $ 133 $ 448 $ 2,419 $ — $ 4,433 Insurance receivables 874 1,048 254 12 3 — 2,191 Deferred acquisition costs 314 225 87 — — — 626 Goodwill 117 — 29 — — — 146 Insurance reserves Claim and claim adjustment expenses 6,224 8,760 1,343 3,373 2,560 — 22,260 Unearned premiums 1,941 1,375 450 147 — (1 ) 3,912 Future policy benefits — — — 10,491 — — 10,491 Three months ended March 31, 2016 Specialty Commercial International Life & Group Non-Core Corporate & Other Non-Core (In millions) Eliminations Total Operating revenues Net earned premiums $ 682 $ 688 $ 198 $ 131 $ — $ — $ 1,699 Net investment income 107 126 12 187 3 — 435 Other revenues 87 6 1 — 3 — 97 Total operating revenues 876 820 211 318 6 — 2,231 Claims, Benefits and Expenses Net incurred claims and benefits 390 442 121 323 128 — 1,404 Policyholders’ dividends 1 3 — — — — 4 Amortization of deferred acquisition costs 144 116 47 — — — 307 Other insurance related expenses 75 141 28 33 — — 277 Other expenses 75 5 9 3 54 — 146 Total claims, benefits and expenses 685 707 205 359 182 — 2,138 Operating income (loss) before income tax 191 113 6 (41 ) (176 ) — 93 Income tax (expense) benefit on operating income (loss) (64 ) (39 ) — 39 62 — (2 ) Net operating income (loss) 127 74 6 (2 ) (114 ) — 91 Net realized investment gains (losses) (11 ) (18 ) 4 (3 ) (8 ) — (36 ) Income tax (expense) benefit on net realized investment gains (losses) 4 6 (1 ) — 2 — 11 Net realized investment gains (losses), after tax (7 ) (12 ) 3 (3 ) (6 ) — (25 ) Net income (loss) $ 120 $ 62 $ 9 $ (5 ) $ (120 ) $ — $ 66 March 31, 2016 (In millions) Reinsurance receivables $ 765 $ 623 $ 139 $ 496 $ 2,707 $ — $ 4,730 Insurance receivables 884 1,025 276 14 2 — 2,201 Deferred acquisition costs 309 225 88 — — — 622 Goodwill 117 — 33 — — — 150 Insurance reserves Claim and claim adjustment expenses 6,325 9,095 1,395 3,311 2,892 — 23,018 Unearned premiums 1,861 1,347 464 136 — (1 ) 3,807 Future policy benefits — — — 10,500 — — 10,500 |
Revenues by line of business | The following table presents revenue by line of business for each reportable segment. Revenues are comprised of operating revenues and net realized investment gains and losses. Three months ended March 31 (In millions) 2017 2016 Specialty Management & Professional Liability $ 661 $ 618 Surety 123 127 Warranty & Alternative Risks 134 120 Specialty revenues 918 865 Commercial Middle Market 458 401 Small Business 97 143 Other Commercial Insurance 294 258 Commercial revenues 849 802 International Canada 51 50 CNA Europe 73 78 Hardy 91 87 International revenues 215 215 Life & Group Non-Core revenues 341 315 Corporate & Other Non-Core revenues 7 (2 ) Eliminations — — Total revenues $ 2,330 $ 2,195 |
General - Narrative (Details)
General - Narrative (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2017USD ($) | |
Noncontrolling Interest [Line Items] | |
Employee service share-based compensation, tax benefit realized from exercise of stock options | $ 3 |
CNAF Consolidated | Loews | |
Noncontrolling Interest [Line Items] | |
Ownership percentage of outstanding common stock of CNAF | 90.00% |
Earnings Per Share - Narrative
Earnings Per Share - Narrative (Details) - shares shares in Thousands | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Earnings Per Share [Abstract] | ||
Incremental common shares attributable to dilutive effect of share-based payment arrangements | 974 | 542 |
Antidilutive securities excluded from computation of earnings per share, amount | 148 | 180 |
Investments - Narrative (Detail
Investments - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2016 | Mar. 31, 2017 | Dec. 31, 2016 | |
Investments [Abstract] | |||
Net realized investment losses | $ 8 | ||
Redemption senior notes | $ 350 | ||
Reduction of net unrealized gains on investments included in AOCI due to shadow adjustments | $ 1,060 | $ 1,014 | |
Embedded derivative notional value | 172 | 174 | |
Embedded derivative fair value | 2 | $ 3 | |
Future capital call commitments for limited partnership investments | 394 | ||
Mortgage loan commitments | 46 | ||
Commitments to purchase or fund privately placed debt securities | 217 | ||
Commitments to sell various privately placed debt securities | $ 196 |
Investments - Net investment in
Investments - Net investment income (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Net Investment Income [Line Items] | ||
Gross investment income | $ 559 | $ 449 |
Investment expense | (14) | (14) |
Net investment income | 545 | 435 |
Fixed maturity securities | ||
Net Investment Income [Line Items] | ||
Gross investment income | 455 | 446 |
Equity securities | ||
Net Investment Income [Line Items] | ||
Gross investment income | 1 | 3 |
Limited partnership investments | ||
Net Investment Income [Line Items] | ||
Gross investment income | 90 | (14) |
Mortgage loans | ||
Net Investment Income [Line Items] | ||
Gross investment income | 7 | 9 |
Short term investments | ||
Net Investment Income [Line Items] | ||
Gross investment income | 3 | 3 |
Trading portfolio | ||
Net Investment Income [Line Items] | ||
Gross investment income | 2 | 2 |
Other | ||
Net Investment Income [Line Items] | ||
Gross investment income | $ 1 | $ 0 |
Investments - Net realized inve
Investments - Net realized investment gains (losses) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Schedule of Available-for-sale Securities [Line Items] | ||
Net realized investment gains (losses) on fixed maturity securities | $ 36 | $ (36) |
Fixed maturity securities | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Gross realized gains | 49 | 45 |
Gross realized losses | (17) | (62) |
Net realized investment gains (losses) on fixed maturity securities | 32 | (17) |
Equity securities | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Gross realized gains | 0 | 0 |
Gross realized losses | 0 | (5) |
Net realized investment gains (losses) on fixed maturity securities | 0 | (5) |
Derivatives | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Net realized investment gains (losses) on fixed maturity securities | 1 | (7) |
Short term investments and other | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Net realized investment gains (losses) on fixed maturity securities | $ 3 | $ (7) |
Investments - Components of oth
Investments - Components of other-than-temporary impairment losses recognized in earnings (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Schedule of Available-for-sale Securities [Line Items] | ||
OTTI losses recognized in earnings | $ 2 | $ 23 |
Corporate and other bonds | ||
Schedule of Available-for-sale Securities [Line Items] | ||
OTTI losses recognized in earnings | 2 | 16 |
Residential mortgage-backed | ||
Schedule of Available-for-sale Securities [Line Items] | ||
OTTI losses recognized in earnings | 0 | 0 |
Other asset-backed | ||
Schedule of Available-for-sale Securities [Line Items] | ||
OTTI losses recognized in earnings | 0 | 2 |
Total asset-backed | ||
Schedule of Available-for-sale Securities [Line Items] | ||
OTTI losses recognized in earnings | 0 | 2 |
Total fixed maturity securities available-for-sale | ||
Schedule of Available-for-sale Securities [Line Items] | ||
OTTI losses recognized in earnings | 2 | 18 |
Equity securities available-for-sale -- Common stock | ||
Schedule of Available-for-sale Securities [Line Items] | ||
OTTI losses recognized in earnings | $ 0 | $ 5 |
Investments - Summary of fixed
Investments - Summary of fixed maturity and equity securities (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | $ 38,381 | $ 38,467 |
Gross Unrealized Gains | 2,863 | 2,744 |
Gross Unrealized Losses | 144 | 196 |
Estimated Fair Value | 41,100 | 41,015 |
Corporate and other bonds | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 17,838 | 17,711 |
Gross Unrealized Gains | 1,428 | 1,323 |
Gross Unrealized Losses | 37 | 76 |
Estimated Fair Value | 19,229 | 18,958 |
Unrealized OTTI Losses (Gains) | (1) | (1) |
States, municipalities and political subdivisions | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 12,261 | 12,060 |
Gross Unrealized Gains | 1,219 | 1,213 |
Gross Unrealized Losses | 31 | 33 |
Estimated Fair Value | 13,449 | 13,240 |
Unrealized OTTI Losses (Gains) | (12) | (16) |
Residential mortgage-backed | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 4,672 | 5,004 |
Gross Unrealized Gains | 121 | 120 |
Gross Unrealized Losses | 50 | 51 |
Estimated Fair Value | 4,743 | 5,073 |
Unrealized OTTI Losses (Gains) | (27) | (28) |
Commercial mortgage-backed | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 1,902 | 2,016 |
Gross Unrealized Gains | 52 | 48 |
Gross Unrealized Losses | 19 | 24 |
Estimated Fair Value | 1,935 | 2,040 |
Unrealized OTTI Losses (Gains) | 0 | 0 |
Other asset-backed | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 1,043 | 1,022 |
Gross Unrealized Gains | 10 | 8 |
Gross Unrealized Losses | 4 | 5 |
Estimated Fair Value | 1,049 | 1,025 |
Unrealized OTTI Losses (Gains) | 0 | 0 |
Total asset-backed | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 7,617 | 8,042 |
Gross Unrealized Gains | 183 | 176 |
Gross Unrealized Losses | 73 | 80 |
Estimated Fair Value | 7,727 | 8,138 |
Unrealized OTTI Losses (Gains) | (27) | (28) |
U.S. Treasury and obligations of government-sponsored enterprises | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 95 | 83 |
Gross Unrealized Gains | 8 | 10 |
Gross Unrealized Losses | 0 | 0 |
Estimated Fair Value | 103 | 93 |
Unrealized OTTI Losses (Gains) | 0 | 0 |
Foreign government | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 419 | 435 |
Gross Unrealized Gains | 14 | 13 |
Gross Unrealized Losses | 1 | 3 |
Estimated Fair Value | 432 | 445 |
Unrealized OTTI Losses (Gains) | 0 | 0 |
Redeemable preferred stock | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 19 | 18 |
Gross Unrealized Gains | 1 | 1 |
Gross Unrealized Losses | 0 | 0 |
Estimated Fair Value | 20 | 19 |
Unrealized OTTI Losses (Gains) | 0 | 0 |
Total fixed maturity securities available-for-sale | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 38,249 | 38,349 |
Gross Unrealized Gains | 2,853 | 2,736 |
Gross Unrealized Losses | 142 | 192 |
Estimated Fair Value | 40,960 | 40,893 |
Unrealized OTTI Losses (Gains) | (40) | (45) |
Total fixed maturity securities trading | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Total fixed maturity securities trading, cost | 20 | 12 |
Total fixed maturity securities trading, fair value | 20 | 12 |
Equity securities available-for-sale -- Common stock | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 20 | 13 |
Gross Unrealized Gains | 5 | 6 |
Gross Unrealized Losses | 0 | 0 |
Estimated Fair Value | 25 | 19 |
Preferred stock | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 92 | 93 |
Gross Unrealized Gains | 5 | 2 |
Gross Unrealized Losses | 2 | 4 |
Estimated Fair Value | 95 | 91 |
Equity securities | ||
Schedule of Available-for-Sale and Trading Securities [Line Items] | ||
Cost or Amortized Cost | 112 | 106 |
Gross Unrealized Gains | 10 | 8 |
Gross Unrealized Losses | 2 | 4 |
Estimated Fair Value | $ 120 | $ 110 |
Investments - Securities in a g
Investments - Securities in a gross unrealized loss position (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | $ 5,931 | $ 6,989 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 126 | 167 |
Estimated fair value, 12 months or longer | 504 | 584 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 18 | 29 |
Estimated fair value, total | 6,435 | 7,573 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 144 | 196 |
Corporate and other bonds | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 1,915 | 2,615 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 29 | 61 |
Estimated fair value, 12 months or longer | 134 | 254 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 8 | 15 |
Estimated fair value, total | 2,049 | 2,869 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 37 | 76 |
States, municipalities and political subdivisions | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 845 | 959 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 31 | 32 |
Estimated fair value, 12 months or longer | 33 | 23 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 0 | 1 |
Estimated fair value, total | 878 | 982 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 31 | 33 |
Residential mortgage-backed | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 2,188 | 2,136 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 44 | 44 |
Estimated fair value, 12 months or longer | 170 | 201 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 6 | 7 |
Estimated fair value, total | 2,358 | 2,337 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 50 | 51 |
Commercial mortgage-backed | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 590 | 756 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 15 | 22 |
Estimated fair value, 12 months or longer | 139 | 69 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 4 | 2 |
Estimated fair value, total | 729 | 825 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 19 | 24 |
Other asset-backed | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 256 | 398 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 4 | 5 |
Estimated fair value, 12 months or longer | 28 | 24 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 0 | 0 |
Estimated fair value, total | 284 | 422 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 4 | 5 |
Total asset-backed | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 3,034 | 3,290 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 63 | 71 |
Estimated fair value, 12 months or longer | 337 | 294 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 10 | 9 |
Estimated fair value, total | 3,371 | 3,584 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 73 | 80 |
U.S. Treasury and obligations of government-sponsored enterprises | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 31 | 5 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 0 | 0 |
Estimated fair value, 12 months or longer | 0 | 0 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 0 | 0 |
Estimated fair value, total | 31 | 5 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 0 | 0 |
Foreign government | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 89 | 108 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 1 | 3 |
Estimated fair value, 12 months or longer | 0 | 0 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 0 | 0 |
Estimated fair value, total | 89 | 108 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 1 | 3 |
Total fixed maturity securities available-for-sale | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 5,914 | 6,977 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 124 | 167 |
Estimated fair value, 12 months or longer | 504 | 571 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 18 | 25 |
Estimated fair value, total | 6,418 | 7,548 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 142 | 192 |
Equity securities available-for-sale -- Common stock | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 2 | |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 0 | |
Estimated fair value, 12 months or longer | 0 | |
Estimated fair value, total | 2 | |
Equity securities available-for-sale -- Preferred stock | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 15 | 12 |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 2 | 0 |
Estimated fair value, 12 months or longer | 0 | 13 |
Available-for-sale securities, continuous unrealized loss position, 12 months or longer, accumulated loss | 4 | |
Estimated fair value, total | 15 | 25 |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | 2 | $ 4 |
Equity securities | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Estimated fair value, less than 12 months | 17 | |
Available-for-sale securities, continuous unrealized loss position, less than 12 months, accumulated loss | 2 | |
Estimated fair value, 12 months or longer | 0 | |
Estimated fair value, total | 17 | |
Available-for-sale securities, continuous unrealized loss position, accumulated loss | $ 2 |
Investments - Activity related
Investments - Activity related to the pretax fixed maturity credit loss component reflected within retained earnings for securities still held for which a portion of an OTTI loss was recognized in OCI (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward] | ||
Beginning balance of credit losses on fixed maturity securities | $ 36 | $ 53 |
Reductions for securities sold during the period | (4) | (5) |
Ending balance of credit losses on fixed maturity securities | $ 32 | $ 48 |
Investments - Contractual matur
Investments - Contractual maturity (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Available-for-sale Securities, Debt Maturities, Single Maturity Date, Amortized Cost Basis [Abstract] | ||
Due in one year or less, cost or amortized cost | $ 1,655 | $ 1,779 |
Due after one year through five years, cost or amortized cost | 7,539 | 7,566 |
Due after five years through ten years, cost or amortized cost | 15,645 | 15,892 |
Due after ten years, cost or amortized cost | 13,410 | 13,112 |
Total Amortized Cost Basis | 38,249 | 38,349 |
Available-for-sale Securities, Debt Maturities, Single Maturity Date [Abstract] | ||
Due in one year or less, estimated fair value | 1,701 | 1,828 |
Due after one year through five years, estimated fair value | 7,918 | 7,955 |
Due after five years through ten years, estimated fair value | 16,176 | 16,332 |
Due after ten years, estimated fair value | 15,165 | 14,778 |
Total Estimated Fair Value | $ 40,960 | $ 40,893 |
Fair Value - Narrative (Details
Fair Value - Narrative (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2016 | |
Fair Value Disclosures [Abstract] | |||
Fair value, assets, level 2 to level 1, transfers | $ 0 | $ 0 | |
Fair value, assets, level 1 to level 2, transfers | 0 | $ 0 | |
Other invested assets overseas deposit | 35,000,000 | $ 31,000,000 | |
Life settlement contracts, fair value | $ 46,000,000 | $ 58,000,000 |
Fair Value - Assets and liabili
Fair Value - Assets and liabilities measured at fair value on a recurring basis (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | $ 42,205 | $ 42,406 |
Liabilities | (2) | (3) |
Corporate and other bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 19,246 | 18,970 |
States, municipalities and political subdivisions | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 13,452 | 13,240 |
Residential mortgage-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 4,743 | 5,073 |
Commercial mortgage-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 1,935 | 2,040 |
Other asset-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 1,049 | 1,025 |
Total asset-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 7,727 | 8,138 |
U.S. Treasury and obligations of government-sponsored enterprises | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 103 | 93 |
Foreign government | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 432 | 445 |
Redeemable preferred stock | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 20 | 19 |
Fixed maturity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 40,980 | 40,905 |
Equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 120 | 110 |
Other invested assets | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 5 | 5 |
Short term investments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 1,054 | 1,328 |
Life settlement contracts, included in Other assets | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 46 | 58 |
Other liabilities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | (2) | (3) |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 449 | 678 |
Liabilities | 0 | 0 |
Level 1 | Corporate and other bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 1 | States, municipalities and political subdivisions | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 1 | Residential mortgage-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 1 | Commercial mortgage-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 1 | Other asset-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 1 | Total asset-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 1 | U.S. Treasury and obligations of government-sponsored enterprises | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 103 | 93 |
Level 1 | Foreign government | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 1 | Redeemable preferred stock | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 20 | 19 |
Level 1 | Fixed maturity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 123 | 112 |
Level 1 | Equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 101 | 91 |
Level 1 | Other invested assets | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 1 | Short term investments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 225 | 475 |
Level 1 | Life settlement contracts, included in Other assets | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 1 | Other liabilities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | 0 | 0 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 41,313 | 41,321 |
Liabilities | (2) | (3) |
Level 2 | Corporate and other bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 19,125 | 18,840 |
Level 2 | States, municipalities and political subdivisions | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 13,451 | 13,239 |
Level 2 | Residential mortgage-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 4,617 | 4,944 |
Level 2 | Commercial mortgage-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 1,922 | 2,027 |
Level 2 | Other asset-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 932 | 968 |
Level 2 | Total asset-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 7,471 | 7,939 |
Level 2 | U.S. Treasury and obligations of government-sponsored enterprises | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 2 | Foreign government | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 432 | 445 |
Level 2 | Redeemable preferred stock | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 2 | Fixed maturity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 40,479 | 40,463 |
Level 2 | Equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 2 | Other invested assets | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 5 | 5 |
Level 2 | Short term investments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 829 | 853 |
Level 2 | Life settlement contracts, included in Other assets | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 2 | Other liabilities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | (2) | (3) |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 443 | 407 |
Liabilities | 0 | 0 |
Level 3 | Corporate and other bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 121 | 130 |
Level 3 | States, municipalities and political subdivisions | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 1 | 1 |
Level 3 | Residential mortgage-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 126 | 129 |
Level 3 | Commercial mortgage-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 13 | 13 |
Level 3 | Other asset-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 117 | 57 |
Level 3 | Total asset-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 256 | 199 |
Level 3 | U.S. Treasury and obligations of government-sponsored enterprises | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 3 | Foreign government | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 3 | Redeemable preferred stock | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 3 | Fixed maturity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 378 | 330 |
Level 3 | Equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 19 | 19 |
Level 3 | Other invested assets | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 3 | Short term investments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 0 | 0 |
Level 3 | Life settlement contracts, included in Other assets | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 46 | 58 |
Level 3 | Other liabilities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | $ 0 | $ 0 |
Fair Value - Reconciliation for
Fair Value - Reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | $ 407 | $ 473 |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | 7 | 4 |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 4 | 3 |
Purchases | 44 | 62 |
Sales | (17) | (16) |
Settlements | (25) | (14) |
Transfers into Level 3 | 28 | 2 |
Transfers out of Level 3 | (5) | (23) |
Balance, end of year | 443 | 491 |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | 0 | 1 |
Corporate and other bonds | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | 130 | 168 |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | 0 | (1) |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 1 | 4 |
Purchases | 5 | 53 |
Sales | (1) | (16) |
Settlements | (14) | (3) |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | (12) |
Balance, end of year | 121 | 193 |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | 0 | 0 |
States, municipalities and political subdivisions | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | 1 | 2 |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | 0 | 0 |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 0 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Balance, end of year | 1 | 2 |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | 0 | 0 |
Residential mortgage-backed | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | 129 | 134 |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | 1 | 1 |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 2 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Settlements | (6) | (5) |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | (2) |
Balance, end of year | 126 | 128 |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | 0 | 0 |
Commercial mortgage-backed | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | 13 | 22 |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | 0 | 0 |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 0 | 0 |
Purchases | 0 | 9 |
Sales | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | (4) |
Balance, end of year | 13 | 27 |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | 0 | 0 |
Other asset-backed | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | 57 | 53 |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | (1) | 0 |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 0 | 0 |
Purchases | 38 | 0 |
Sales | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 28 | 2 |
Transfers out of Level 3 | (5) | (5) |
Balance, end of year | 117 | 50 |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | 0 | 0 |
Total asset-backed | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | 199 | 209 |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | 0 | 1 |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 2 | 0 |
Purchases | 38 | 9 |
Sales | 0 | 0 |
Settlements | (6) | (5) |
Transfers into Level 3 | 28 | 2 |
Transfers out of Level 3 | (5) | (11) |
Balance, end of year | 256 | 205 |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | 0 | 0 |
Fixed maturity securities | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | 330 | 379 |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | 0 | 0 |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 3 | 4 |
Purchases | 43 | 62 |
Sales | (1) | (16) |
Settlements | (20) | (8) |
Transfers into Level 3 | 28 | 2 |
Transfers out of Level 3 | (5) | (23) |
Balance, end of year | 378 | 400 |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | 0 | 0 |
Equity securities | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | 19 | 20 |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | 0 | 0 |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 1 | (1) |
Purchases | 1 | 0 |
Sales | (2) | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Balance, end of year | 19 | 19 |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | 0 | 0 |
Derivatives | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | 0 | |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | 1 | |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 0 | |
Purchases | 0 | |
Sales | (1) | |
Settlements | 0 | |
Transfers into Level 3 | 0 | |
Transfers out of Level 3 | 0 | |
Balance, end of year | 0 | |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | 0 | |
Life settlement contracts, included in Other assets | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, beginning of year | 58 | 74 |
Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss) | 6 | 4 |
Net change in unrealized appreciation (depreciation) included in Other comprehensive income (loss) | 0 | 0 |
Purchases | 0 | 0 |
Sales | (13) | 0 |
Settlements | (5) | (6) |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Balance, end of year | 46 | 72 |
Unrealized gains (losses) on Level 3 assets and liabilities held as of March 31, 2017 recognized in Net income (loss) | $ 0 | $ 1 |
Fair Value - Quantitative infor
Fair Value - Quantitative information about significant unobservable inputs in the fair value measurement of level 3 assets (Details) - Fixed maturity securities - Income Approach Valuation Technique - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Fair Value Inputs, Assets, Quantitative Information [Line Items] | ||
Estimated Fair Value (In millions) | $ 122 | $ 106 |
Minimum | ||
Fair Value Inputs, Assets, Quantitative Information [Line Items] | ||
Credit spread | 2.00% | 2.00% |
Maximum | ||
Fair Value Inputs, Assets, Quantitative Information [Line Items] | ||
Credit spread | 40.00% | 40.00% |
Weighted Average | ||
Fair Value Inputs, Assets, Quantitative Information [Line Items] | ||
Credit spread | 4.00% | 4.00% |
Fair Value - Carrying amount an
Fair Value - Carrying amount and estimated fair value of financial instrument assets and liabilities which are not measured at fair value (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Assets | ||
Mortgage loans | $ 611 | $ 591 |
Liabilities | ||
Short term debt | 150 | 0 |
Long term debt | 2,560 | 2,710 |
Carrying Amount | ||
Assets | ||
Mortgage loans | 611 | 591 |
Note receivable | 10 | |
Liabilities | ||
Short term debt | 150 | |
Long term debt | 2,560 | 2,710 |
Estimated Fair Value | ||
Assets | ||
Mortgage loans | 616 | 594 |
Note receivable | 10 | |
Liabilities | ||
Short term debt | 156 | |
Long term debt | 2,811 | 2,952 |
Level 1 | Estimated Fair Value | ||
Assets | ||
Mortgage loans | 0 | 0 |
Note receivable | 0 | |
Liabilities | ||
Short term debt | 0 | |
Long term debt | 0 | 0 |
Level 2 | Estimated Fair Value | ||
Assets | ||
Mortgage loans | 0 | 0 |
Note receivable | 0 | |
Liabilities | ||
Short term debt | 156 | |
Long term debt | 2,811 | 2,952 |
Level 3 | Estimated Fair Value | ||
Assets | ||
Mortgage loans | 616 | 594 |
Note receivable | 10 | |
Liabilities | ||
Short term debt | 0 | |
Long term debt | $ 0 | $ 0 |
Claim and Claim Adjustment Ex39
Claim and Claim Adjustment Expense Reserves - Narrative (Details) - USD ($) | 3 Months Ended | |||
Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2016 | Dec. 31, 2010 | |
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Catastrophe losses net of reinsurance | $ 34,000,000 | $ 36,000,000 | ||
Loss Portfolio Transfer | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net A&EP claim and allocated claim adjustment expense reserves ceded to NICO | $ 1,600,000,000 | |||
Aggregate limit under A&EP Loss Portfolio Transfer | 4,000,000,000 | |||
A&EP claim and allocated claim adjustment expense reserves ceded under existing third party reinsurance contracts transferred to NICO under A&EP Loss Portfolio Transfer | 1,200,000,000 | |||
Reinsurance premium paid to NICO under A&EP Loss Portfolio Transfer | 2,000,000,000 | |||
Net reinsurance receivables transferred to NICO under A&EP Loss Portfolio Transfer | 215,000,000 | |||
Total consideration paid to NICO under AEP Loss Portfolio Transfer | $ 2,200,000,000 | |||
Net A&EP adverse development before consideration of LPT | 60,000,000 | $ 200,000,000 | ||
Cumulative amounts ceded under AEP Loss Portfolio Transfer | 2,900,000,000 | $ 2,800,000,000 | ||
Deferred reinsurance benefit yet to be recognized | 354,000,000 | 334,000,000 | ||
Fair value of collateral trust account established by NICO under A&EP Loss Portfolio Transfer | $ 2,700,000,000 | $ 2,800,000,000 |
Claim and Claim Adjustment Ex40
Claim and Claim Adjustment Expense Reserves - Reconciliation of claim and claim adjustment expense reserves (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] | ||
Gross, beginning of year | $ 22,343 | $ 22,663 |
Ceded, beginning of year | 4,094 | 4,087 |
Net reserves, beginning of year | 18,249 | 18,576 |
Net incurred claim and claim adjustment expenses: | ||
Provision for insured events of current year | 1,207 | 1,224 |
Decrease in provision for insured events of prior years | (82) | (45) |
Amortization of discount | 48 | 48 |
Total net incurred | 1,173 | 1,227 |
Net payments attributable to: | ||
Current year events | (68) | (76) |
Prior year events | (1,184) | (1,147) |
Total net payments | (1,252) | (1,223) |
Foreign currency translation adjustment and other | 14 | 39 |
Net reserves, end of period | 18,184 | 18,619 |
Ceded reserves, end of year | 4,076 | 4,399 |
Gross reserves, end of year | $ 22,260 | $ 23,018 |
Claim and Claim Adjustment Ex41
Claim and Claim Adjustment Expense Reserves - Net prior year development (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Segment Reporting Information [Line Items] | ||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ (57) | $ (52) |
Pretax (favorable) unfavorable premium development | 25 | (14) |
Total pretax (favorable) unfavorable net prior year development | (32) | (66) |
Specialty | ||
Segment Reporting Information [Line Items] | ||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | (31) | (34) |
Pretax (favorable) unfavorable premium development | (5) | (11) |
Total pretax (favorable) unfavorable net prior year development | (36) | (45) |
Commercial | ||
Segment Reporting Information [Line Items] | ||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | (24) | (14) |
Pretax (favorable) unfavorable premium development | 37 | (2) |
Total pretax (favorable) unfavorable net prior year development | 13 | (16) |
International | ||
Segment Reporting Information [Line Items] | ||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | (2) | (4) |
Pretax (favorable) unfavorable premium development | (7) | (1) |
Total pretax (favorable) unfavorable net prior year development | (9) | (5) |
Corporate & Other Non-Core | ||
Segment Reporting Information [Line Items] | ||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | 0 | 0 |
Pretax (favorable) unfavorable premium development | 0 | 0 |
Total pretax (favorable) unfavorable net prior year development | $ 0 | $ 0 |
Claim and Claim Adjustment Ex42
Claim and Claim Adjustment Expense Reserves - Net prior year claim and allocated claim adjustment expense reserve development for Specialty segment (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Liability for Claims and Claims Adjustment Expense [Line Items] | ||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ (57) | $ (52) |
Specialty | ||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||
Medical Professional Liability | 1 | (7) |
Other Professional Liability and Management Liability | (32) | (9) |
Surety | 0 | 0 |
Warranty | 0 | 2 |
Other | 0 | (20) |
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ (31) | $ (34) |
Claim and Claim Adjustment Ex43
Claim and Claim Adjustment Expense Reserves - Net prior year claim and allocated claim adjustment expense reserve development for Commercial segment (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Liability for Claims and Claims Adjustment Expense [Line Items] | ||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ (57) | $ (52) |
Commercial | ||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||
Commercial Auto | (26) | (15) |
General Liability | 0 | (15) |
Workers' Compensation | 0 | 4 |
Property and Other | 2 | 12 |
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ (24) | $ (14) |
Claim and Claim Adjustment Ex44
Claim and Claim Adjustment Expense Reserves - Net prior year claim and allocated claim adjustment expense reserve development for International segment (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Liability for Claims and Claims Adjustment Expense [Line Items] | ||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ (57) | $ (52) |
International | ||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||
Medical Professional Liability | 0 | 0 |
Medical Professional Liability | (1) | (1) |
Other Professional Liability | 0 | 0 |
Liability | 1 | (4) |
Other | (2) | 1 |
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ (2) | $ (4) |
Claim and Claim Adjustment Ex45
Claim and Claim Adjustment Expense Reserves - Impact of Loss Portfolio Transfer on the Consolidated Statement of Operations (Details) - Loss Portfolio Transfer - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Liability for Claims and Claims Adjustment Expense [Line Items] | ||
Net A&EP adverse development before consideration of LPT | $ 60 | $ 200 |
Retroactive reinsurance benefit recognized | (40) | (73) |
Pretax impact of A&EP reserve development and the LPT | $ 20 | $ 127 |
Legal Proceedings and Guarant46
Legal Proceedings and Guarantees - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Dec. 31, 2016 | |
Legal Proceedings, Commitments and Contingencies, and Guarantees [Line Items] | ||
Reduction to earned premium due to the small business premium rate adjustment contingency | $ 42 | $ 16 |
Guarantee Obligations | ||
Legal Proceedings, Commitments and Contingencies, and Guarantees [Line Items] | ||
Guarantor obligations, maximum exposure, undiscounted | 1,800 | |
Indemnification Agreement | ||
Legal Proceedings, Commitments and Contingencies, and Guarantees [Line Items] | ||
Guarantor obligations, maximum exposure, undiscounted | 254 | |
Guarantee agreement | ||
Legal Proceedings, Commitments and Contingencies, and Guarantees [Line Items] | ||
Guarantor obligations, maximum exposure, undiscounted | 434 | |
Guarantee and Indemnification | ||
Legal Proceedings, Commitments and Contingencies, and Guarantees [Line Items] | ||
Guarantor obligations, current carrying value | 5 | $ 5 |
Insurance Premium Rate Adjustment | ||
Legal Proceedings, Commitments and Contingencies, and Guarantees [Line Items] | ||
Interest due to policyholders | 5 | |
Multi-Peril Package Product | Insurance Premium Rate Adjustment | ||
Legal Proceedings, Commitments and Contingencies, and Guarantees [Line Items] | ||
Loss contingency accrual | 36 | |
Accident and Health Insurance Product Line | Insurance Premium Rate Adjustment | ||
Legal Proceedings, Commitments and Contingencies, and Guarantees [Line Items] | ||
Loss contingency accrual | $ 50 |
Benefit Plans - Components of n
Benefit Plans - Components of net periodic cost (benefit) (Details) - Pension Plans, Defined Benefit - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Defined Benefit Plan Disclosure [Line Items] | ||
Interest cost on projected benefit obligation | $ 26 | $ 28 |
Expected return on plan assets | (39) | (40) |
Amortization of net actuarial loss | 9 | 9 |
Settlement loss | 2 | 0 |
Net periodic pension cost (benefit) | $ (2) | $ (3) |
Accumulated Other Comprehensi48
Accumulated Other Comprehensive Income (Loss) by Component - Changes in accumulated other comprehensive income (loss) by component (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Balance, beginning of year | $ 11,969 | |
Other comprehensive income (loss) before reclassifications | 96 | $ 240 |
Amounts reclassified from accumulated other comprehensive income (loss) after tax (expense) benefit | 15 | (19) |
Other comprehensive income (loss) after tax (expense) benefit | 81 | 259 |
Balance, end of period | 11,693 | 11,470 |
Reclassification from AOCI, current period, tax | (7) | 11 |
Tax (expense) benefit on other comprehensive income (loss) | (41) | (122) |
Net unrealized gains (losses) on investments with OTTI losses | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Balance, beginning of year | 30 | 27 |
Other comprehensive income (loss) before reclassifications | 0 | 3 |
Amounts reclassified from accumulated other comprehensive income (loss) after tax (expense) benefit | 4 | (2) |
Other comprehensive income (loss) after tax (expense) benefit | (4) | 5 |
Balance, end of period | 26 | 32 |
Reclassification from AOCI, current period, tax | (2) | 1 |
Tax (expense) benefit on other comprehensive income (loss) | 1 | (3) |
Net unrealized gains (losses) on other investments | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Balance, beginning of year | 642 | 390 |
Other comprehensive income (loss) before reclassifications | 85 | 223 |
Amounts reclassified from accumulated other comprehensive income (loss) after tax (expense) benefit | 18 | (11) |
Other comprehensive income (loss) after tax (expense) benefit | 67 | 234 |
Balance, end of period | 709 | 624 |
Reclassification from AOCI, current period, tax | (9) | 7 |
Tax (expense) benefit on other comprehensive income (loss) | (38) | (116) |
Pension and postretirement benefits | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Balance, beginning of year | (647) | (648) |
Other comprehensive income (loss) before reclassifications | 0 | 0 |
Amounts reclassified from accumulated other comprehensive income (loss) after tax (expense) benefit | (7) | (6) |
Other comprehensive income (loss) after tax (expense) benefit | 7 | 6 |
Balance, end of period | (640) | (642) |
Reclassification from AOCI, current period, tax | 4 | 3 |
Tax (expense) benefit on other comprehensive income (loss) | (4) | (3) |
Cumulative foreign currency translation adjustment | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Balance, beginning of year | (198) | (84) |
Other comprehensive income (loss) before reclassifications | 11 | 14 |
Amounts reclassified from accumulated other comprehensive income (loss) after tax (expense) benefit | 0 | 0 |
Other comprehensive income (loss) after tax (expense) benefit | 11 | 14 |
Balance, end of period | (187) | (70) |
Reclassification from AOCI, current period, tax | 0 | 0 |
Tax (expense) benefit on other comprehensive income (loss) | 0 | 0 |
AOCI Attributable to Parent | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Balance, beginning of year | (173) | (315) |
Balance, end of period | $ (92) | $ (56) |
Business Segments - Narrative (
Business Segments - Narrative (Details) | 3 Months Ended |
Mar. 31, 2017segments | |
Core Segments - Specialty, Commercial and International | |
Segment Reporting Information [Line Items] | |
Number of operating segments | 3 |
Non-Core Segments - Life & Group Non-Core and Corporate and Other Non-Core | |
Segment Reporting Information [Line Items] | |
Number of operating segments | 2 |
Business Segments - Income Stat
Business Segments - Income Statement Information (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Operating revenues | ||
Net earned premiums | $ 1,645 | $ 1,699 |
Net investment income | 545 | 435 |
Other revenues | 104 | 97 |
Total operating revenues | 2,294 | 2,231 |
Claims, Benefits and Expenses | ||
Net incurred claims and benefits | 1,289 | 1,404 |
Policyholders’ dividends | 4 | 4 |
Amortization of deferred acquisition costs | 305 | 307 |
Other insurance related expenses | 254 | 277 |
Other expenses | 135 | 146 |
Total claims, benefits and expenses | 1,987 | 2,138 |
Operating income (loss) before income tax | 307 | 93 |
Income tax (expense) benefit on operating income (loss) | (72) | (2) |
Net operating income (loss) | 235 | 91 |
Net realized investment gains (losses) | 36 | (36) |
Income tax (expense) benefit on net realized investment gains (losses) | (11) | 11 |
Net realized investment gains (losses), after tax | 25 | (25) |
Net income (loss) | 260 | 66 |
Operating Segments | Specialty | ||
Operating revenues | ||
Net earned premiums | 664 | 682 |
Net investment income | 153 | 107 |
Other revenues | 94 | 87 |
Total operating revenues | 911 | 876 |
Claims, Benefits and Expenses | ||
Net incurred claims and benefits | 386 | 390 |
Policyholders’ dividends | 1 | 1 |
Amortization of deferred acquisition costs | 143 | 144 |
Other insurance related expenses | 69 | 75 |
Other expenses | 81 | 75 |
Total claims, benefits and expenses | 680 | 685 |
Operating income (loss) before income tax | 231 | 191 |
Income tax (expense) benefit on operating income (loss) | (77) | (64) |
Net operating income (loss) | 154 | 127 |
Net realized investment gains (losses) | 7 | (11) |
Income tax (expense) benefit on net realized investment gains (losses) | (3) | 4 |
Net realized investment gains (losses), after tax | 4 | (7) |
Net income (loss) | 158 | 120 |
Operating Segments | Commercial | ||
Operating revenues | ||
Net earned premiums | 651 | 688 |
Net investment income | 178 | 126 |
Other revenues | 9 | 6 |
Total operating revenues | 838 | 820 |
Claims, Benefits and Expenses | ||
Net incurred claims and benefits | 437 | 442 |
Policyholders’ dividends | 3 | 3 |
Amortization of deferred acquisition costs | 116 | 116 |
Other insurance related expenses | 126 | 141 |
Other expenses | 14 | 5 |
Total claims, benefits and expenses | 696 | 707 |
Operating income (loss) before income tax | 142 | 113 |
Income tax (expense) benefit on operating income (loss) | (48) | (39) |
Net operating income (loss) | 94 | 74 |
Net realized investment gains (losses) | 11 | (18) |
Income tax (expense) benefit on net realized investment gains (losses) | (3) | 6 |
Net realized investment gains (losses), after tax | 8 | (12) |
Net income (loss) | 102 | 62 |
Operating Segments | International | ||
Operating revenues | ||
Net earned premiums | 197 | 198 |
Net investment income | 12 | 12 |
Other revenues | 0 | 1 |
Total operating revenues | 209 | 211 |
Claims, Benefits and Expenses | ||
Net incurred claims and benefits | 115 | 121 |
Policyholders’ dividends | 0 | 0 |
Amortization of deferred acquisition costs | 46 | 47 |
Other insurance related expenses | 27 | 28 |
Other expenses | (6) | 9 |
Total claims, benefits and expenses | 182 | 205 |
Operating income (loss) before income tax | 27 | 6 |
Income tax (expense) benefit on operating income (loss) | (7) | 0 |
Net operating income (loss) | 20 | 6 |
Net realized investment gains (losses) | 6 | 4 |
Income tax (expense) benefit on net realized investment gains (losses) | (1) | (1) |
Net realized investment gains (losses), after tax | 5 | 3 |
Net income (loss) | 25 | 9 |
Operating Segments | Life & Group Non-Core | ||
Operating revenues | ||
Net earned premiums | 133 | 131 |
Net investment income | 197 | 187 |
Other revenues | 1 | 0 |
Total operating revenues | 331 | 318 |
Claims, Benefits and Expenses | ||
Net incurred claims and benefits | 330 | 323 |
Policyholders’ dividends | 0 | 0 |
Amortization of deferred acquisition costs | 0 | 0 |
Other insurance related expenses | 32 | 33 |
Other expenses | 2 | 3 |
Total claims, benefits and expenses | 364 | 359 |
Operating income (loss) before income tax | (33) | (41) |
Income tax (expense) benefit on operating income (loss) | 37 | 39 |
Net operating income (loss) | 4 | (2) |
Net realized investment gains (losses) | 10 | (3) |
Income tax (expense) benefit on net realized investment gains (losses) | (4) | 0 |
Net realized investment gains (losses), after tax | 6 | (3) |
Net income (loss) | 10 | (5) |
Operating Segments | Corporate & Other Non-Core | ||
Operating revenues | ||
Net earned premiums | 0 | 0 |
Net investment income | 5 | 3 |
Other revenues | 0 | 3 |
Total operating revenues | 5 | 6 |
Claims, Benefits and Expenses | ||
Net incurred claims and benefits | 21 | 128 |
Policyholders’ dividends | 0 | 0 |
Amortization of deferred acquisition costs | 0 | 0 |
Other insurance related expenses | 0 | 0 |
Other expenses | 44 | 54 |
Total claims, benefits and expenses | 65 | 182 |
Operating income (loss) before income tax | (60) | (176) |
Income tax (expense) benefit on operating income (loss) | 23 | 62 |
Net operating income (loss) | (37) | (114) |
Net realized investment gains (losses) | 2 | (8) |
Income tax (expense) benefit on net realized investment gains (losses) | 0 | 2 |
Net realized investment gains (losses), after tax | 2 | (6) |
Net income (loss) | (35) | (120) |
Intersegment Eliminations | ||
Operating revenues | ||
Net earned premiums | 0 | 0 |
Net investment income | 0 | 0 |
Other revenues | 0 | 0 |
Total operating revenues | 0 | 0 |
Claims, Benefits and Expenses | ||
Net incurred claims and benefits | 0 | 0 |
Policyholders’ dividends | 0 | 0 |
Amortization of deferred acquisition costs | 0 | 0 |
Other insurance related expenses | 0 | 0 |
Other expenses | 0 | 0 |
Total claims, benefits and expenses | 0 | 0 |
Operating income (loss) before income tax | 0 | 0 |
Income tax (expense) benefit on operating income (loss) | 0 | 0 |
Net operating income (loss) | 0 | 0 |
Net realized investment gains (losses) | 0 | 0 |
Income tax (expense) benefit on net realized investment gains (losses) | 0 | 0 |
Net realized investment gains (losses), after tax | 0 | 0 |
Net income (loss) | $ 0 | $ 0 |
Business Segments - Balance She
Business Segments - Balance Sheet Information (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 | Mar. 31, 2016 |
Segment Reporting Information [Line Items] | |||
Reinsurance receivables | $ 4,433 | $ 4,730 | |
Insurance receivables | 2,191 | 2,201 | |
Deferred acquisition costs | 626 | $ 600 | 622 |
Goodwill | 146 | 145 | 150 |
Insurance reserves | |||
Claim and claim adjustment expenses | 22,260 | 22,343 | 23,018 |
Unearned premiums | 3,912 | 3,762 | 3,807 |
Future policy benefits | 10,491 | $ 10,326 | 10,500 |
Operating Segments | Specialty | |||
Segment Reporting Information [Line Items] | |||
Reinsurance receivables | 817 | 765 | |
Insurance receivables | 874 | 884 | |
Deferred acquisition costs | 314 | 309 | |
Goodwill | 117 | 117 | |
Insurance reserves | |||
Claim and claim adjustment expenses | 6,224 | 6,325 | |
Unearned premiums | 1,941 | 1,861 | |
Future policy benefits | 0 | 0 | |
Operating Segments | Commercial | |||
Segment Reporting Information [Line Items] | |||
Reinsurance receivables | 616 | 623 | |
Insurance receivables | 1,048 | 1,025 | |
Deferred acquisition costs | 225 | 225 | |
Goodwill | 0 | 0 | |
Insurance reserves | |||
Claim and claim adjustment expenses | 8,760 | 9,095 | |
Unearned premiums | 1,375 | 1,347 | |
Future policy benefits | 0 | 0 | |
Operating Segments | International | |||
Segment Reporting Information [Line Items] | |||
Reinsurance receivables | 133 | 139 | |
Insurance receivables | 254 | 276 | |
Deferred acquisition costs | 87 | 88 | |
Goodwill | 29 | 33 | |
Insurance reserves | |||
Claim and claim adjustment expenses | 1,343 | 1,395 | |
Unearned premiums | 450 | 464 | |
Future policy benefits | 0 | 0 | |
Operating Segments | Life & Group Non-Core | |||
Segment Reporting Information [Line Items] | |||
Reinsurance receivables | 448 | 496 | |
Insurance receivables | 12 | 14 | |
Deferred acquisition costs | 0 | 0 | |
Goodwill | 0 | 0 | |
Insurance reserves | |||
Claim and claim adjustment expenses | 3,373 | 3,311 | |
Unearned premiums | 147 | 136 | |
Future policy benefits | 10,491 | 10,500 | |
Operating Segments | Corporate & Other Non-Core | |||
Segment Reporting Information [Line Items] | |||
Reinsurance receivables | 2,419 | 2,707 | |
Insurance receivables | 3 | 2 | |
Deferred acquisition costs | 0 | 0 | |
Goodwill | 0 | 0 | |
Insurance reserves | |||
Claim and claim adjustment expenses | 2,560 | 2,892 | |
Unearned premiums | 0 | 0 | |
Future policy benefits | 0 | 0 | |
Intersegment Eliminations | |||
Segment Reporting Information [Line Items] | |||
Reinsurance receivables | 0 | 0 | |
Insurance receivables | 0 | 0 | |
Deferred acquisition costs | 0 | 0 | |
Goodwill | 0 | 0 | |
Insurance reserves | |||
Claim and claim adjustment expenses | 0 | 0 | |
Unearned premiums | (1) | (1) | |
Future policy benefits | $ 0 | $ 0 |
Business Segments - Revenues by
Business Segments - Revenues by Line of Business (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Segment Reporting Information [Line Items] | ||
Revenues | $ 2,330 | $ 2,195 |
Operating Segments | Specialty | ||
Segment Reporting Information [Line Items] | ||
Revenues | 918 | 865 |
Operating Segments | Commercial | ||
Segment Reporting Information [Line Items] | ||
Revenues | 849 | 802 |
Operating Segments | International | ||
Segment Reporting Information [Line Items] | ||
Revenues | 215 | 215 |
Operating Segments | Life & Group Non-Core | ||
Segment Reporting Information [Line Items] | ||
Revenues | 341 | 315 |
Operating Segments | Corporate & Other Non-Core | ||
Segment Reporting Information [Line Items] | ||
Revenues | 7 | (2) |
Intersegment Eliminations | ||
Segment Reporting Information [Line Items] | ||
Revenues | 0 | 0 |
Specialty | Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Revenues | 661 | 618 |
Surety | Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Revenues | 123 | 127 |
Warranty & Alternative Risks | Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Revenues | 134 | 120 |
Middle Market | Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Revenues | 458 | 401 |
Small Business | Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Revenues | 97 | 143 |
Other Commercial Insurance | Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Revenues | 294 | 258 |
Canada | Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Revenues | 51 | 50 |
CNA Europe | Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Revenues | 73 | 78 |
Hardy | Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Revenues | $ 91 | $ 87 |